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Hybrid biomaterials combining bioactive glasses (BAG) and natural polymers such as gelatin, 
are potential alternatives for bone tissue engineering applications. The inorganic and organic 
phases in a hybrid interact at a molecular scale and are connected via covalent bonds due to 
coupling agents such as 3-glycidoxypropyl trimethoxysilane (GPTMS). Owing to the strong 
covalent bonding between phases it is possible to create materials with controllable degradation 
(both aqueous and enzymatic), and bioactivity. Furthermore, the rheological properties of the 
materials can be adjusted to increase the mechanical properties and/or allow shaping of the 
hybrid into a specific shape.   
In this study, hybrids with either silicate glass S53P4, or Mg and Sr-doped borosilicate glass 
B12.5 –Mg 5- Sr 10 (“mix”) combined to organic gelatin phase were synthesized with different 
weight ratios between phases: 30/70 (glass/gelatin), 15/85, 5/95 and 1/99. The aim of this study 
was to assess in vitro properties of these hybrid biomaterials. The bioactivity and degradation 
behaviour of the hybrids were investigated in Simulated Body Fluid (SBF) and in enzymatic 
collagenase solution. SBF dissolution experiment was carried out for two weeks, and enzymatic 
degradation experiment for six hours. At every time point, samples’ mass loss and ion release 
behaviour were studied, and SBF samples’ pH changes were measured.  
For further characterization of the hybrids, rheological measurements were performed to 
understand the gelation behaviour of the hybrids, and thermogravimetric analysis (TGA) to assess 
the inorganic/organic phase ratio.  
In addition, the biocompatibility of BAG/gelatin hybrid materials were evaluated by culturing 
human-derived mesenchymal stem cells (hBMSCs) in contact with hybrid samples and with hybrid 
dissolution product extracts. Furthermore, the ion concentrations in cell culturing medium upon 
culturing were also measured.  
Based on the results, the hybrids were stable in aqueous solutions, and exhibited controlled 
ion release suggesting hydroxyapatite (HA) layer precipitation. The hybrids were also more 
resistant to enzymatic degradation than the gelatin alone. However, based on the Live/Dead 
results all hybrid compositions showed an inhibitory effect in hBMSC proliferation after 72 hours 
of culturing, possibly due to too high reactivity or release of unreacted compounds, such as the 
coupling agent GPTMS. Further cell studies and optimization of the hybrid biomaterial are needed 
to confirm the suitability of hybrids as a biocompatible bone tissue engineering scaffold material.  
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Bioaktiivista lasia ja luonnon polymeerejä, kuten gelatiinia yhdistävät hybridibiomateriaalit, 
ovat vaihtoehto luukudosteknologian sovelluksiin. Hybridimateriaalin epäorgaaninen ja 
orgaaninen osa vuorovaikuttavat molekyylitasolla, sillä ne sitoutuvat kovalenttisesti kemiallisten 
kiinnitysaineiden, kuten 3-glysidyloksipropyylitrimetoksisilaanin (GPTMS), ansiosta. Tämän 
vahvan sitoutumisen ansiosta hybridit ovat helpommin muotoiltavissa, niiden bioaktiivisuutta ja 
liukenemisnopeutta sekä mekaanisia ominaisuuksia voidaan säädellä tarpeen mukaan. 
Tässä työssä tutkittiin useita erilaisia hybridimateriaaleja. Gelatiinin kanssa yhdistettiin 
bioaktiivista lasia eri painoprosenttisuhteilla (30/70 (lasi/gelatiini), 15/85, 5/95 ja 1/99). Laseina 
käytettiin joko S53P4 -silikaattilasia tai Mg- ja Sr- ioneja sisältävää B12.5 –Mg 5- Sr10 -
borosilikaattilasia. Työn tavoitteena oli vertailla ja tutkia hybridien in vitro -ominaisuuksia. 
Hybridien bioaktiivisuutta ja liukenemista tutkittiin sekä fysiologisia nesteitä simuloivassa SBF-
liuoksessa että kollagenaasi-entsyymiliuoksessa. SBF -dissoluutiosarjaa jatkettiin kaksi viikkoa, 
ja entsymaattista hajotusta seurattiin kuuden tunnin ajan. Tietyissä aikapisteissä tarkasteltiin 
hybridinäytteiden massan muutosta, pH-arvoa sekä ICP-OES -mittauksella ionien vapautumista.  
Lisäksi hybridien geeliytymistä tutkittiin reologisilla mittauksilla, ja todellista suhdetta 
epäorgaanisen ja orgaanisen osan välillä analysoitiin termogravimetrisillä mittauksilla.  
Työn toisena tavoitteena oli arvioida hybridien biosoveltuvuutta.  Ihmisen luuytimen 
mesenkymaalisia kantasoluja viljeltiin kontaktissa hybridinäytteiden sekä niiden 
liukenemistuotteiden kanssa. Lisäksi vapautuvat ionikonsentraatiot analysoitiin ICP-OES -
mittauksella.  
Tulosten perusteella hybridit käyttäytyivät stabiilisti nesteympäristössä, ja liukenivat 
vapauttaen tasaisesti bioaktiivisuutta osoittavia ioneja. Hybridit vastustivat entsymaattista 
hajotusta hieman pelkkää orgaanista gelatiinia tehokkaammin. Kuitenkin Live/Dead -koetulosten 
perusteella hybridit rajoittivat solujen jakautumista 72 tunnin viljelyn jälkeen. Solujen heikko 
uusiutuminen johtuu todennäköisesti hybrideistä ylimäärin vapautuvasta reagoimattomasta 
GPTMS – kiinnitysaineesta. Jotta hybridien bioyhteensopivuus, ja näin ollen mahdollinen käyttö 
luukudosteknologiassa, voidaan varmistaa, tulee hybridien koostumusta optimoida ja jatkaa 
soluviljelytutkimuksia.  
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LIST OF SYMBOLS AND ABBREVIATIONS 
 
 
45S5 Bioglass, bioactive glass with composition of 45 wt% SiO2, 24.5 wt% 
CaO, 24.5 wt% Na2O, and 6.0 wt% P2O5 
58S bioactive glass (58% SiO2, 33% CaO and 9% P2O5, based on mol%) 
APTES (3-Aminopropyl)triethoxysilane 
B  Boron 
BAG  Bioactive glass 
BMP bone morphogenetic proteins 
Ca Calcium 
CF  C-factor, molar ratio of GPTMS and gelatin 
DPBS Dulbecco's phosphate-buffered saline 
EDC 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride 
ESC  embryonic stem cell 
FGF-2 basic fibroblast growth factor 
G* complex shear modulus 
G’ storage modulus 
G’’ loss modulus 
GPTMS 3-glycidoxypropyl trimethoxysilane 
hASC human adipose stem cells 
hBMSC human bone marrow-derived mesenchymal stem cells 
HCA carbonated hydroxyapatite 
HCl hydrochloric acid 
HLA-DR Human Leukocyte Antigen – DR isotype 
ICP-OES inductively coupled plasma optical emission spectrometry 
ICPTES 3-(Triethoxysilyl)propyl isocyanate 
IGF insulin-like growth factor 
iPSCs induced pluripotent stem cell 
LVE linear viscoelastic range 
MC3T3-E1 pre-osteoblastic cell line from mouse 
Mg  Magnesium  
mix abbreviation for B12,5 –Mg5 –Sr10 doped borosilicate bioactive 
glass 
mol-% Mol percent 
MSC mesenchymal stem cell 
Na Sodium 
P Phosphorus 
PCL polycaprolactone 
PDGF Platelet-derived growth factor 
PDMS Polydimethylsiloxane 
PEG Polyethylene glycol 
PGA polyglycolic acid 
PHB polyhydroxybutyrate 
PLA  polylactic acid 
PLGA poly lactic-co-glycolic acid 
PRP Platelet rich plasma 
P/S Penicillin/Streptomycin 
S53P4 abbreviation for  
SAOS-2 human primary osteogenic sarcoma cell line 
SBF Simulated Body Fluid  
Si  Silicon 
Sr  Strontium 
  
tan δ loss factor  
TCP tricalcium phosphate 
TEOS tetraethyl orthosilicate 
TEVS triethoxyvinylsilane 
TGA Thermogravimetric analysis 
TGF-β Transforming growth factor beta 
VP N-vinyl pyrrolidone 
wt-% Weight percent 
α-MEM Alpha Modifications Minimum Essential Medium 
γ shear rate 
γ-PGA gamma-polyglutamic acid 
η  viscosity 
τ shear stress 
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1. INTRODUCTION 
Bone –related diseases and subsequent bone loss are a major burden in terms of patient 
quality of life and economic impact. There are multiple causes for bone injuries and 
defects, such as osteoporosis, traumatic injury, orthopaedic surgeries and tumour 
resection. Currently the most used treatment for bone defects is autogenous bone 
grafting, where bone is collected from patient’s own body (autograft), or from other 
humans, typically cadavers (allograft). (Brydone, Meek et al. 2010) 
Autografts and allografts suffer from various limitations, such as lack of supply, risk of 
disease transmission and high cost. To overcome these restrictions, synthetic bone 
substitute biomaterials, such as metallic, ceramic, polymeric or composite biomaterials 
are used. However, there are multiple criteria for bone substitute materials to fulfil. They 
must be biocompatible, possess suitable degradation and mechanical properties, and 
ideally have osteogenic properties. Bioactive biomaterials, such as bioactive glasses 
(BAGs), and other bioceramics, such as β- tricalcium phosphate (TCP), are an attractive 
option to meet these needs. But despite of their bioactivity and osteoconductive 
properties, when bioceramics are used alone, they tend to be too brittle and difficult to 
shape. These concerns of long-term reliability in vivo limit their applications as bone 
replacing biomaterials. (Jones 2013) 
For this reason, focus has turned more on composite materials combining BAG particles 
or fibres within a polymer matrix. However, this approach is not optimal either, due to the 
mismatch in degradation between phases leading to unpredictable in vivo behaviour, 
and limited contact with bone forming cells due to polymer phase masking the bioactive 
components. Due to these challenges, there is a need for a material that can mimic the 
natural bone tissue more effectively while being stable in vivo (Valliant E.M., Jones J.R., 
2011).  
Bone tissue engineering is a popular method to overcome the limitations of autografts 
and allografts. Its key components include biocompatible three –dimensional temporary 
template (scaffold) to guide new bone formation, bone forming cells to lay down bone 
tissue matrix, and an appropriate environment to mature the tissue construct. Ideally 
when combining all these components best results in terms of native bone graft 
mimicking construct would be achieved. (Amini, Laurencin et al. 2012) 
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Natural bone tissue could be described as a nanocomposite material consisting of 
organic phase (collagen fibrils) and inorganic carbonated hydroxyapatite (HCA) crystals. 
Therefore, a hybrid material in which inorganic and organic phases are interacting in 
nanoscale could better mimic natural bone’s structural and functional properties.(Jones 
2013) Opposite to conventional composites, in inorganic/organic class II hybrid material 
the phases are homogeneously dispersed and covalently linked to each other at the 
molecular level. The covalent links are facilitated by reaction with coupling agents, such 
as 3-glycidoxypropyl trimethoxysilane (GPTMS). This way the material can achieve 
synergistic effect combining the properties of both organic and inorganic phases. 
(Kickelbick G., 2006) In the future, inorganic/organic hybrid biomaterials could find 
potential use as a bone scaffold for bone tissue engineering applications.  
 
Figure 1. Introduction of inorganic/organic hybrid biomaterial 
 
The objective of this study was to characterize novel bioactive glass/gelatin GPTMS-
coupled hybrid biomaterials in terms of their bioactivity, degradation behaviour, 
rheological properties, and biocompatibility. This way valuable information about the 
materials suitability for bone tissue engineering applications could be assessed. For 
example, this type of scaffold material could be used as an injectable bone filler or putty-
like material, which would be highly preferred by surgeons due to their ease of handling 
and tailorable properties (Fig 1). 
Firstly, literature review including basics of bone biology and anatomy, current state of 
the art on hybrid biomaterials, rheology and stem cells/hybrid interactions for bone tissue 
engineering and regenerative medicine are covered. The materials and methods used 
to synthesize and characterize the newly developed materials are presented, followed 
by the results and discussion sections. Finally, conclusions are given, focusing on the 
limitations of the developed materials and suggestions for future work.   
Organic 
phase
Coupling 
agent 
Inorganic 
phase
Hybrid material
+  shaping possibilities
+ controllable degradation 
and bioactivity
+ tailorable mechanical 
properties
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2. BONE TISSUE ENGINEERING 
2.1 Structure of bone 
 
Bone is a type of connective tissue consisting of bone cells and mineralized extracellular 
matrix. Its role in human body is to protect and support other organs and enable 
movement. It also acts as a calcium and phosphate storage. The inorganic part of bone, 
bone mineral, is found in the form of hydroxyapatite crystals [Ca10(PO4)6(OH)2]. The 
major structural organic building block of the bone matrix is type I collagen. Furthermore, 
other collagen types such as V, III, XI, and XIII are found in smaller amounts. In addition 
to collagen, other matrix proteins include proteoglycans, glycoproteins (osteonectin, 
osteopontin, podoplanin, dentin matrix protein), bone-specific vitamin K-dependent 
proteins (osteocalcin, protein S) and finally growth factors and cytokines (BMPs, IGFs, 
TGF-β). (Ross, Pawlina 2016) The components of bone matrix are summarized in Figure 
2 below: 
 
 
 
Figure 2. Bone composition 
 
 
Bone Matrix 
components
Collagen (~90%) type I
types V (III, XI, XIII)
Other proteins 
(~10%)
proteoglycans
glycoproteins
growth factors & cytokines
bone-specific proteins
Bone cells osteoprogenitors
osteoblasts
osteocytes
bone-lining cells
osteoclasts
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There are variety of cell types associated with bone. Osteoprogenitor cells are pre-
osteoblast cells committed to bone cell differentiation. They are derived from 
mesenchymal stem cells, which are discussed more in detail later in this thesis. 
Osteoblasts are the matrix secreting cells, which are referred to as osteocytes once they 
get surrounded with secreted matrix. Some osteoblasts after bone deposition stay on the 
bone surface as bone-lining cells. In addition to cells creating new bone, cells resorbing 
bone also exist. These osteoclasts are present where bone is being remodelled or in the 
case of bone damage. (Ross, Pawlina 2016) The cells associated with bone are 
presented in Figure 2. 
In general, bone tissue can be classified either as compact or spongy/cancellous bone. 
Denser compact bone is found outside of the bone while meshwork-like spongy bone 
forms the interior of the bone (Fig. 3). The porous meshwork is continuous and consists 
of bone marrow and blood vessels. Bone marrow is divided to either red or yellow 
marrow. Red marrow is the development site for blood cells and is most abundant in 
young individuals. For adults the fat cell-containing yellow marrow is more prominent.  
 
 
Figure 3. Section of a mature bone  
cancellous bone 
osteon 
osteonal 
canal 
periosteum 
perforating canal  
osteocyte (purple) 
endosteum 
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As seen above, mature bone tissue is composed of cylindrical shaped structural units 
called osteons. In osteon there is bone matrix surrounding the central osteonal canal, 
which contains blood vessels and nerves. In addition to osteonal canals, there are 
perforating canals through periosteal and endosteal surfaces to reach osteonal canal 
and connect canals to each other. Periosteum is a fibrous membrane, which covers the 
outer surface of bones. Correspondingly, the lining facing the marrow cavity is referred 
to as endosteum. (Ross, Pawlina 2016) 
 
2.2 Bone regeneration 
Process of fracture healing consists of four main steps. These steps, including 
inflammation, proliferation, soft callus formation and finally hard callus formation are 
combined in Figure 4.  
 
Figure 4. Fracture healing model steps, adapted from  (Arun, Alvarez, 
et al., 2014) 
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First, hematoma or blood clot forms at the fracture site. This hematoma consists of 
platelets, leukocytes, macrophages, growth factors and cytokines, and it plays an 
important role in later bone regeneration. This step is often referred to as destructive 
phase, and it is characterized by inflammation, activity of pro-inflammatory cytokines, 
such platelet-derived growth factor (PDGF), or platelet-rich plasma (PRP), and local 
hypoxia. Hypoxia stimulates the formation of new vasculature (angiogenesis), which 
correspondingly leads to the second step of fracture healing process: recruitment of 
mesenchymal stem cells to the site. These cells can differentiate into chondrocytes and 
osteoblasts. Differentiation occurs under biological cues such as bone morphogenetic 
proteins (BMPs). Chondrocytes form cartilage matrix first, which is later substituted by 
bone formation by osteoblasts. For this reason, the third step includes the formation of 
soft cartilaginous scaffold, which is substituted in the last step by new deposited bone. 
Chondrocytes undergo programmed cell death (apoptosis), and finally over the course 
of months to years, osteoblasts and bone resorbing osteoclasts continue bone 
remodelling leading to indistinguishable new bone at the fracture site. (Arun, Alvarez et 
al., 2014) 
 
2.3 Current methods to treat bone defects 
 
The history of bone-grafting traces as back as the 17th century, when the first 
documented bone graft was performed by a Dutch surgeon Job van Meekeren. This 
bone graft was a xenograft, which refers to a tissue or organ derived from other species, 
in this case a piece of a dog skull. (Donati, Zolezzi et al. 2007) Currently, the standard 
treatment is an autograft, bone from the patient’s own body, from donor site to defect 
site. The donor site is usually the top of the pelvis (iliac crest), or for spinal surgery it 
could also be bone spurs from the vertebrae. In addition to autografts, allografts, which 
are harvested from other humans (often cadavers), are used. Both options possess 
advantages but also multiple disadvantages. Autografts are preferred over allografts due 
to the increased graft integrity due to vascularization, however, they suffer from limited 
supply and discomfort to patients. Use of allografts eliminates donor site morbidity, but 
there is a risk for disease transmission, and increase risk for graft rejection. (Ghanbari, 
Vakili‐ ghartavol 2016) 
Synthetic substitutes can overcome some limitations of autografts and allografts, since 
they are easier to sterilize, they are available in unlimited quantities and in different 
shapes and sizes. Synthetic bone graft materials can be made from natural or synthetic 
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polymers, ceramics, metals or composites. The most common ceramic materials for this 
use are often a mix of hydroxyapatite (HA) and tricalcium phosphate (TCP), 
manufactured in variety of forms including granules and porous blocks. (Jones 2012) 
Most research of polymers suitable for bone graft substitutes has focused on polylactic 
acid  (PLA) , polyglycolic acid (PGA)  and poly lactic-co-glycolic acid (PLGA) copolymers 
(Campana, Milano et al. 2014). Metallic implants made of, for example, titanium are 
strong and tough to resist crack propagation, and therefore they are suitable for load 
bearing applications. However, since metal is a bioinert material, fibrous encapsulation 
can occur, and healthy bone will never re-form on the site. Furthermore, the body is likely 
to eventually reject the implant, and higher risk for fatigue loading and infection exists. 
(Jones 2012)  
Bioactive glass, which will be discussed more in detail in this work, is beneficial since it 
is bioactive, and, depending of its composition, can bond with both bone and soft tissue. 
However, concerns, such as brittleness and long-term mechanical reliability in vivo, are 
hindering their use as bone substitute materials. (Jones 2013) Furthermore, processing 
into three-dimensional scaffolds of the highly bioactive and commercially available 
silicate glasses remains a challenge due to their rapid crystallization during sintering 
(Massera, Fagerlund et al. 2012). For these reasons BAGs are often combined with for 
example biodegradable polymers to form composite materials. However, possible 
mismatch in the degradation rate between the glass and the polymer might lead to 
loosening of the glass phase, and to difficulties in predicting the overall degradation 
behaviour. (Jones 2013) 
 
2.4 Bone tissue engineering 
 
Current alternatives to bone grafts lack several important key properties. For instance, 
they cannot be loaded with osteogenic cells, they do not have sufficient mechanical 
properties, and they should include added compounds, such as vascular endothelial 
growth factor (VEGF) or bone morphogenetic proteins (BMPs) to promote 
vascularization and osteoinduction. Typically, such pro-angiogenic and osteogenic 
molecules are expensive and can have negative effects, such as ectopic bone formation  
(Oryan, Alidadi et al. 2014)  Tissue engineering is making an attempt to solve these 
drawbacks. 
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Tissue engineering is defined as an interdisciplinary field that applies the principles of 
engineering and life sciences towards the development of biological substitutes that 
restore, maintain, or improve tissue function. (Langer, Vacanti 1993) In essence, 
functional living tissue can be fabricated using living cells, which are usually associated 
with a matrix or scaffold to guide new tissue development. A scaffold stands for a three-
dimensional temporary support structure for tissue forming cells to synthesize new tissue 
in desired shape and dimensions. (Rahaman, Day et al. 2011) In the context of bone 
regeneration, mimicking the natural bone (autograft) is the best current option available. 
To achieve this, multiple widely accepted design criteria are made. 
First of all, the scaffold needs to be three dimensional with interconnected pores, so that 
it is possible to seed cells and other relevant biological moieties inside, and that it can 
later support fluid flow, cell migration, and new tissue and blood vessel formation into the 
scaffold. In addition, the scaffold must be biocompatible, and it needs to promote 
osteogenic cell attachment and function. One other important aspect is the material 
degradation rate that, ultimately, should match the rate of new tissue formation without 
releasing any toxic by-products. Furthermore, the mechanical properties of the scaffold 
should mimic natural bone in order to survive physiological stresses at the implantation 
site in vivo. (Rahaman, Day et al. 2011) 
Finally, other important aspects should also be noted, such as scalability (possibility for 
mass-production), easy sterilization, and the regulatory requirements needed to fulfil in 
order to get clinical use for the product. The user experience also matters, because the 
surgeons are known to prefer materials that could be cut to shape in theatre to fit the 
defect.  (Gao, Rahaman et al. 2013, Jones 2013)  
Some potential scaffold types for bone tissue engineering can be divided in three main 
categories: natural, synthetic and mineral-based. Firstly, natural scaffolds include 
biodegradable natural polymers and polysaccharides such as collagen, hyaluronic acid, 
alginate and chitosan. Challenge in using natural scaffolds is their lack of mechanical 
stability and difficulty to sterilize without disrupting their structure. The use of synthetic 
polymers such as polylactic acid (PLA), polyglycolic acid (PGA), polydioxanone (PDS) 
and polycaprolactone (PCL) would improve the mechanical properties without 
compromising biodegradability. However, they lack osteoinductive properties, which 
could be achieved by using bioactive scaffold materials such as calcium phosphate 
ceramics and bioactive glass. (Montoro, Wan et al. 2014) 
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2.5 Stem cells in bone tissue engineering 
 
The bone tissue engineering approach often involves the use of mesenchymal stem cells 
(MSCs) seeded into three-dimensional scaffold material and induced to generate new 
bone by osteoinductive cues. Especially bone-marrow derived mesenchymal stem cells 
(BMSCs) are used due to their high osteogenic potential. (Yousefi, James et al. 2016) 
Therefore, this chapter will focus on BMSCs after general introduction to stem cells.  
Stem cell is defined as a cell that has the capacity to renew itself and to differentiate into 
other cell types of the body. Stem cells can be classified by dividing them into groups 
according to their differentiation potential. Totipotent stem cells are the earliest cells in 
mammal embryo development, and they can differentiate into all the possible cell types 
to form the whole embryo. Pluripotent stem cells, such as cells from the inner cell mass 
of the blastocyst, embryonic stem cells (ESCs), and induced pluripotent stem cells 
(iPSCs) can differentiate into all the cells of all the three embryonic germ layers, but are 
not able to form a complete embryo. Multipotent stem cells, such as mesenchymal stem 
cells or other adult stem cells, can differentiate into multiple cell lineages. And finally, 
unipotent stem cells, such as spermatogonial stem cells, can only differentiate into one 
mature cell lineage. (Samadikuchaksaraei, Lecht et al. 2014) 
Mesenchymal stem cells (MSCs) are multipotent stem cells capable of self-renewal, 
plasticity and ability to differentiate into multiple cell lineages. They are a heterogenous 
population of fibroblast-like cells from tissues of mesodermal origin. MSCs were first 
isolated and characterized from bone marrow in 1970s, but the term MSC came officially 
in the use only in early 1990s. Other typical sources to harvest MSCs include umbilical 
cord, placenta, blood, adipose tissue, and dental tissues. (Andrzejewska, Lukomska et 
al. 2019) 
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Figure 5. MSC differentiation into multiple cell types 
 
 
Specific criteria to define MSCs exists. Firstly, MSCs need to be plastic-adherent in 
standard culture conditions. Secondly, ≥95% of the MSC population must express 
surface markers STRO-1, SB-10, Sh3 (CD73) and SH4 antigens as well as Thy-1 
(CD90), TGF-β receptor type III endoglin (CD105), hyaluronic acid receptor CD44, 
integrin α1 subunit CD29, activated leukocyte-cell adhesion molecules (ALCAM, 
CD166), and possibly others. Thirdly, they should lack expression to the hematopoietic 
markers CD19/CD79a, CD34, CD45, CD11b/CD14 and HLA-DR. And finally, they must 
able to differentiate into osteoblasts (bone cells), chondroblasts (cartilage cells) and 
adipocytes (fat cells) under standard in vitro differentiating conditions (Fig. 5). (Dominici, 
Le Blanc et al. 2006)  
Bone marrow derived stem cells (BMSCs) are considered to be promising in bone tissue 
engineering applications. They could be harvested directly from patient’s own bone 
marrow, and they are thought to be responsible for natural bone repair process, where 
they differentiate into osteoblasts. As seen in Figure 6, they are fibroblast-like cells with 
spindle-like and stellate morphology.  
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Figure 6. Morphology of BMSCs in culturing flask, x10 objective: 
spindle, stellate, irregular  
 
MSCs have been shown to have hypoimmunogenic properties: they are able to modulate 
immune cell phenotypes and to immunosuppress the local environment. However, their 
use is limited by the low frequency within bone marrow stroma. In addition, MSCs in 
general have high variation between different donors. For instance, the age, gender, 
extraction site, and physical condition can play important role in the quality of harvested 
MSCs. (Andrzejewska, Lukomska et al. 2019) Other challenges include high cost of 
serum and growth factor supplements needed in their in vitro expansion (Montoro, Wan 
et al. 2014). 
BMSCs, and other MSCs such as adipose stem cells (ASCs) have been widely studied 
with many silicate bioactive glasses, and found to support their proliferation and 
differentiation functions in in vitro cell culture (Bosetti, Cannas 2005, Radin, Reilly et al. 
2005, Rahaman, Day et al. 2011). In contrast, borate and borosilicate bioactive glasses 
have shown lower ability to support cell proliferation due to their faster degradation rate 
and pH increasing effect of releasing boron (Rahaman, Day et al. 2011, Ojansivu, Mishra 
et al. 2018). However, despite the reduced cell proliferation, the dissolution products of 
the glass have been found to stimulate osteogenic commitment and upregulate 
endothelial markers (Ojansivu, Mishra et al. 2018). 
The use of hBMSCs with hybrid materials will be discussed in more detail in the following 
chapter.  
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3. HYBRID BIOMATERIAL 
Conventional bioactive glass-containing composites are usually prepared by 
incorporating bioactive glass particles in biodegradable polymer matrix. Most used 
polymers include polyesters such as polylactic acid (PLA), polyglycolic acid (PGA), and 
poly(lactic-co-glycolic) acid (PLGA). Polymers, such as PLA or polyhydroxybutyrate 
(PHB), have also been applied as coatings to highly porous glass-ceramic foam scaffolds 
to improve resistance to fractures, but there are doubts over the effectiveness in terms 
of cellular response. (Jones 2013) However, these conventional composites suffer from 
multiple limitations. One concern is the lack of bioactive surface, such as in the case of 
polymer coatings on BAGs. Also the polymer matrix can “mask” bioactive glass particles, 
which leads to osteoprogenitor cells not being able to encounter glass but only polymer 
(Fig. 7). Other issues include mismatch in the degradation rate of the composites 
components, which causes instability of the scaffold. For example, the commonly used 
polyesters degrade by self-catalytic hydrolysis, which leads to rapid loss of mechanical 
properties. (Valliant, Jones 2011) 
 
 
Figure 7. Issue with conventional composites: bioactive glass particles 
(white) embedded in polymer matrix. Cells can contact only few 
particles limiting bioactivity (Jones 2012) 
 
In order to overcome these issues, a new type of biomaterial named hybrid material has 
been developed. Hybrid materials act as one phase due to their interpenetrating organic-
inorganic networks interacting at the nanoscale (Novak 1993). With hybrids it is possible 
to combine properties of different phases effectively: for example, the high bioactivity of 
BAG, toughness of polymers, and controlled congruent degradation by balancing the 
ratio of the phases. Hybrids differ from nanocomposites because their components 
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cannot be distinguished above nanoscale. The so-called true hybrid behaves as one 
material phase, while it exploits the benefits of each individual phase. (Mahony, Yue et 
al. 2014) 
Hybrid materials can be divided into two classes depending on the interactions between 
inorganic and organic components (Fig. 8). Class I hybrids contain only weak bonding, 
such as hydrogen bonds, or van der Waals forces. They are usually prepared by 
incorporating a soluble polymer into inorganic sol, and entrapping polymer into silica 
network during network condensation. The challenges of these hybrids include the lack 
of chemical bonds between the inorganic and the organic phases, which can lead to 
rapid dissolution behaviour (Valliant, Jones 2011, Poologasundarampillai, Maçon 2016). 
Class II hybrids differ from class I hybrids because they have covalent bonding between 
the components. In order to form covalent bonds, a coupling agent (a molecule) is 
needed. In earlier studies the use of silica-containing polymers, such as 
polydimethylsiloxane (PDMS) was investigated, but due to biostability of those polymers, 
they are not suitable for tissue engineering applications (Novak 1993, Valliant, Jones 
2011). 
 
Figure 8. Class I and Class II hybrid classification, adapted from 
(Mondal 2018) 
 
Inorganic-organic solids are usually prepared by exploiting the sol-gel process. The used 
polymer is added early to the process so that the silica network can form around it. The 
conventional sol-gel process is modified in terms of thermal processing, since most 
hybrid systems need aging and drying below 100 °C. In addition, control of the pH -value 
is very crucial in this process: it affects the functionalization of the polymer, and the 
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gelation of the silica network. For instance, too acidic pH might cause degradation of 
certain polymers during the synthesis. (Jones 2013) 
There are multiple challenges involved in hybrid material development. First, hybrid 
synthesis is complex and challenging due to the heavy chemistry involved. Also since 
the inorganic phase of hybrids have been mainly from tetraethyl orthosilicate (TEOS) in 
previous studies, the main challenge has been the difficult incorporation of calcium ions 
into the silicate network. It is essential to incorporate calcium if the material is meant to 
have the osteoinductive properties of bioactive glasses. (Jones 2013) In sol-gel synthesis 
adding of metal salts with calcium require high temperature treatment above 400 °C. 
Alternatively, the use of calcium alkoxide precursors in room temperature might lead to 
impossible handling of the hybrid sol due to premature gelation. Therefore, mostly pure 
silica-polymer hybrids are done with heterogeneous calcium deposits outside the silicate 
network. The issue with these deposits is their rapid dissolution: they get washed away 
in aqueous environment, causing burst release of ions and rapid pH increase. (Lao, 
Dieudonné et al. 2016)  
 
3.1 Inorganic component: Bioactive glass 
Bioactive glass was discovered by Professor Larry Hench at the University of Florida in 
1969. He discovered a degradable glass with composition 46.1 SiO2- 24.4 Na2O- 26.9 
CaO - 2.6 P2O5 (mol%), which was later named as 45S5 Bioglass. Bioglass was found 
to form strong bond to bone, which started a whole new field of bioactive ceramics. 
(Hench, Splinter et al. 1971)  
Bioactive material can be defined as a material that stimulates a beneficial response 
from the body, particularly bonding to host tissue. (Hench 2006) Bioactive glass is 
especially beneficial in bone applications, because it doesn’t only bond with bone rapidly, 
but also stimulates bone growth away from the bone-implant surface (osteoinduction) by 
stimulating genes associated with osteoblast differentiation. While glass bonds to bone, 
carbonated hydroxyapatite layer (HCA) starts to precipitate at the surface. HCA is very 
similar to natural bone mineral, and it is believed to interact with collagen fibrils to 
integrate with bone. The reason for these osteoinductive properties of bioactive glass 
lies in the dissolution products, such as soluble silica and calcium ions that stimulate 
osteogenic cells to produce bone matrix. (Hench 2006) 
It is important to understand the atomic structure of glass in order to study its properties. 
In general, bioactive glasses consist of glass formers, network modifiers and 
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intermediates. Silicate glasses consist of silica tetrahedra connected by -Si-O-Si- 
bridging oxygen bonds, Si being the network forming atom. Network modifiers include 
Na and Ca, since they disrupt the Si network by forming non-bridging oxygen bonds (Fig. 
9). It has been shown that P is isolated from silica network, and no P-O-Si bonds form 
unless the glass contains more than 50 mol% of P. This explains why P is rapidly lost 
upon immersion in aqueous solution. In the case of borate- or phosphate glasses the 
network former is either boron trioxide (B2O3) or phosphorus pentoxide (P2O5), 
respectively. (Stanić 2017) 
 
 
Figure 9. Bioactive glass network, adapted from (Stanić 2017) 
 
It has been shown that the accumulation of dissolution products from the glass leads to 
changes in the glass chemical composition and change in the surrounding pH, which 
leads to HCA nucleation. (Hench 1998, Jones 2012) The whole multistep process can 
be described as follow:  
Firstly, rapid ion exchange occurs on the glass surface: H+ ions from the solution are 
exchanged with network modifier cations Ca2+ or Na+ of the glass. This ion exchange 
creates silanol bonds Si-OH on the glass surface: 
 
Si-O-Na++ H++ OH- → Si-OH+ + Na+(aq) + OH- 
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The pH value increases due to both the consumption of H+ ions, and the release of 
alkali-metal and alkaline-earth ions. Because of that, the cation depleted silica-rich region 
starts to form near the glass surface. Phosphate, if present in the glass composition, is 
lost from composition during this phase, because it is isolated from the silica network. 
High local pH leads to OH- ions attacking the silica network, breaking Si-O-Si bonds. 
Soluble silica is lost as silicic acid Si(OH)4 to the solution, and more silanols are left on 
the glass surface: 
 
Si-O-Si + H2O → Si -OH + OH -Si 
 
After these steps occurs the condensation of Si-OH groups near the glass surface and 
the repolymerization of silica rich cation-depleted layer. Next, Ca2+ and PO43- groups 
migrate through the silica rich layer and from the solution. They form an amorphous CaO-
P2O5 layer on top of the silica gel layer (Fig. 10). Finally, OH- and carbonate (CO3)2- from 
solution are incorporated in the amorphous CaO-P2O5 film which crystallizes into HCA 
layer.  
 
Figure 10. Mechanism of HCA layer formation on the surface of BAGs 
 
After the formation of crystalline HCA layer, following steps are hypothesized to occur:  
First, the biological moieties get absorbed into the HCA layer, following by the action of 
macrophages, attachment and differentiation of stem cells, and finally the generation and 
crystallization of matrix. (Jones 2012)  
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Bioactive glasses can be divided into many subgroups. In addition to conventional 
silicate glasses such as 45S5 or S53P4, for example phosphate- and borate- based 
glasses have been developed. Furthermore, doping of conventional bioactive glasses, 
as well as borate/phosphate variant, with metal ions such as Mg, Sr, and Ag, or trace 
elements such as Cu, Zn and Sr can lead to changes in crystal structure, thermal stability, 
morphology, solubility and chemical and biological properties. In the scope of this thesis 
work, especially important properties include the favourable biological responses such 
as enhanced angiogenesis, osteogenesis and antibacterial activity. Especially in the 
case of bone tissue engineering applications, understanding the role of inorganic ions in 
bone metabolism is crucial. (Hoppe, Güldal et al. 2011, O’Neill, Awale et al. 2018)  
 
 
Figure 11. Ions with osteogenic properties (Mouriño, Vidotto et al. 
2019) 
 
Magnesium is one of the main trace elements in human body and plays an important 
role in the bone development. Mg-ions doped in a glass network are found to stimulate 
new bone formation, and increase bone cell adhesion and stability (Zreiqat, Howlett et 
al. 2002, Yamasaki, Yoshida et al. 2002).  
Strontium is structurally, physically and chemically very similar to calcium, which is why 
it has been widely studied in the context of bone regeneration. For instance, Sr -ions are 
found to be promising in treatment of osteoporosis by inhibiting bone-resorbing 
osteoclast activity (Meunier, Slosman et al. 2002), and beneficial to bone formation in 
vivo (Marie, Ammann et al. 2001, O'Donnell, Candarlioglu et al. 2010, Lao, Jallot et al. 
2008, Gentleman, Fredholm et al. 2010).  
Boron, even though toxic in high concentration, is an essential trace dietary element. It 
has been found to stimulate bone formation, and RNA synthesis in fibroblast cells 
(Dzondo-Gadet, Mayap-Nzietchueng et al. 2002). 
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The modification of the conventional silicate glass network also affects its thermal and 
degradation properties. In the context of BAG dissolution, the rate of HCA layer formation 
indicating bioactivity highly depends on the glass composition. The lower the silica 
content, for example in the case of adding modifying cations, the less connected silica 
network, and this leads to more rapid dissolution of the glass (Hench 1998). 
Addition of boron has been found to form a phase separated glass with regions rich in 
SiO2, and B2O3.Because the borate phase dissolves faster due to higher solubility, 
borosilicate glasses have increased dissolution rate in aqueous environment compared 
to silicate glasses.(Massera, Claireaux et al. 2011, Tainio, Salazar et al. 2020) Partial 
substitution of Ca with Mg has been found to increase durability and contribute toward 
stronger glass network. (Massera, Hupa et al. 2012)  
Two main ways to fabricate bioactive glass include the conventional melt-quenching 
route and the chemistry-based sol-gel route. In melt-quenching the oxides are melted 
together at high temperatures in a platinum crucible, and then quenched in a graphite 
mould or in water. The sol-gel reaction takes place in room temperature, where the glass 
precursors undergo polymer-type reactions to form a gel. The gel consists of a wet 
inorganic network of covalently bonded silica, which is then dried and heated to form a 
glass. The conventional 45S5 and other commercial glasses are prepared by melt-
quenching, and ternary composition glasses such as 58S are fabricated by sol-gel 
method. (Jones 2013)  
The main difference between melt-quenched and sol-gel glasses is that melt-derived 
glasses are dense while sol-gel glasses tend to have inherent nanoporosity (Sepulveda, 
Jones et al. 2001). This porosity increases surface area and thus the reactivity. TEOS 
(tetra-alkyl orthosilicate) is typically used as a sol-gel precursor. Catalytic conditions of 
sol gel process can be acidic, basic, or neutral, and it impacts greatly the structure of the 
inorganic network formed. (Novak 1993) The main disadvantage of sol-gel method is the 
possible shrinking and cracking during gel drying caused by drying stresses that are 
generally attributed to large capillary forces generated in very small pores of the gel 
(Novak 1993).   
3.2 Organic component: Polymers 
The possibilities of preparing an inorganic organic hybrid are almost endless: for 
example, wide range of both natural and synthetic organic polymers as well as inorganic 
metal-oxygen fragments and cationic species can be incorporated in hybrid materials 
(Jones 2013).  
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The choice of polymer can be based on a variety of factors. First, in order to exploit 
hybrids for tissue engineering applications, controllable degradation is important. 
Therefore, the used polymer should be biodegradable. However, it is also essential to 
consider the method of polymer degradation, for example whether it occurs by hydrolysis 
or by enzymatic degradation. Chain scission occurs by reaction between water and 
polymer, where the water splits the polymer chains. Autocatalysis, due to acidic 
oligomers that catalyse further degradation due to local pH increase, leads to rapid and 
unpredictable dissolution. This can be a challenge with conventional polyesters like PGA, 
PLA and their copolymers. In in vivo conditions enzymatic degradation happens resulting 
in reduced chain length of polymers, mainly on the surface because water penetration is 
slower than the rate of degradation. Therefore, even though the size of the scaffold 
becomes smaller, the bulk structure is maintained. These types of degrading scaffolds 
provide longer mechanical stability for the tissue to regenerate.(Dhandayuthapani, 
Yoshida et al. 2012) 
The next important criterion, in the case of hybrids, is whether it is possible to form 
covalent bonds between the inorganic phase and the polymer. This criterion is often 
fulfilled using bifunctional coupling agents, which are discussed more in detail in the next 
chapter. Finally, when choosing the suitable polymer often natural tissue is mimicked. In 
bone tissue engineering applications collagen would be a preference because bones are 
mainly consisting of it. However, collagen is not very soluble and therefore for example 
gelatin, or chitosan are other potential alternatives.(Shirosaki, Osaka et al. 2012) 
Collagen as the most abundant component of the organic part of natural bone would be 
the ideal polymer choice for bone tissue engineering scaffolds. In addition, due to the 
strong triple helix structure of its amino acids, appropriate mechanical properties can be 
achieved. It is often derived from bovine skin and tendons, porcine skin and rat 
tail.(Parenteau-Bareil, Gauvin et al. 2010) Due to its xenogenous nature, there are risks 
associated with the use of collagen, such as possible transmission of diseases. In 
addition, challenges arise from its insolubility. Collagen also varies from batch to batch: 
for example, its degree of cross-linking might vary. Other issues include religious and 
cultural considerations due to the use of porcine derived collagen, and regulatory 
concerns. (Valliant, Jones 2011).  
Gelatin is one attractive option to act as organic phase in hybrid since as a denatured 
form of collagen, it is a major constituent of natural extracellular matrix of all tissues. 
Gelatin is also more a practical choice cost wise than collagen, and it is easily available. 
Gelatin retains the functional groups of collagen along its chains but it is soluble in water, 
which is another benefit. Disadvantages include that the amino acid chains are not 
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necessarily uniform when they come from natural source. Therefore, it is difficult to 
accurately define how many covalent bonds will form between gelatin and silica, as it is 
not known how many functional groups each gelatin molecule will have. (Jones 2013) 
Other polymers studied for the use in inorganic organic hybrids include for example 
chitosan and polycaprolactone (PCL). Moreover, multiple synthetic polymers such as 
polyethylene glycol (PEG) are also experimented in hybrid research. (Jones 2013) 
3.3 Coupling agents 
The coupling agents are usually bifunctional short chain polymers containing 
alkoxysilane groups on one end and another functional group on the other end. The type 
of functional group depends on the polymer. These groups might also be as side chains 
instead of end of the chains. (Valliant, Jones 2011).  
Most common coupling agents include organosilanes such as 3-glycidoxypropyl 
trimethoxysilane (GPTMS), 3-aminopropyltriethoxysilane (APTES), and 3-
isocyanatopropyltriethoxysiloane (ICPTES) (Mahony, Yue et al. 2014) (Fig. 12).  
 
 
 
Figure 12. Chemical structure of most common coupling agents 
 
Out of these options GPTMS is the most widely used in terms of hybrid materials due to 
its inexpensive price, and the ease of polymer functionalization. With GPTMS the 
polymer functionalization can be carried out in single step reaction. GPTMS has an 
epoxy ring on one end, and three methoxysilane groups on the other end of the molecule. 
The epoxy ring is very susceptible to nucleophilic attack, and therefore polymer 
containing nucleophilic groups such as –OH or –COOH can be functionalized with 
GPTMS. (Ren, Tsuru et al. 2001) The hypothesized reaction between GPTMS and 
natural polymer such as gelatin are shown below (Fig. 13):  
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Figure 13. Hypothesized reactions between GPTMS and gelatin, 
adapted from (Ren, Tsuru et al. 2001) 
 
In addition, it is hypothesized that the silanol groups of the GPTMS-functionalized gelatin 
would react to those of bioactive glass (Fig. 14).   
 
Figure 14. Theoretical structure of BAG/gelatin class II hybrid 
biomaterial 
 
Like mentioned earlier, other options for coupling agents exist. For example, in the case 
of ICPTES, the isocyanate functional groups are highly toxic. Therefore, during the hybrid 
synthesis it is challenging to ensure the removal of all unreacted ICPTES. In addition, 
ICPTES is found disadvantageous due to its preferential reactivity towards H2O. For this 
reason, anhydrous solvents must be used, to which for example often used gelatin is 
insoluble. (Connell, Gabrielli et al. 2017).  
While coupling agents are often used, other ways to crosslink natural polymers exist. 
These crosslinkers include for example glutaraldehyde, 1-ethyl-3-(3-
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dimethylaminopropyl)carbodiimide hydrochloride (EDC), and genipin. From those, 
glutaraldehyde is the most common and efficient one. Its aldehyde groups at both ends 
bond covalently to amine groups of polymer chain. It is easily available, inexpensive, but 
concerns exist due to its cytotoxicity upon degradation. (Bigi, Cojazzi et al. 2001) EDC 
is also cytotoxic if it remains unreacted in the solution. It is soluble in water and reacts 
with carboxyl groups on the polymer. Genipin is a non-cytotoxic alternative to 
glutaraldehyde and EDC but it is found much less effective (Bigi, Cojazzi et al. 2002). 
Due to the reasons explained above, these crosslinkers have not been studied in detail 
in the context of hybrid biomaterials.  
Due to the competitive nature of polymerization reactions of inorganic and organic 
network of the hybrid, pH value of the solution is very essential for the functionalization 
to occur. Gabrielli et al. reported that slightly acidic conditions are needed to obtain a 
functionalization through nucleophilic attack because the catalysis is too slow at a neutral 
pH. Nevertheless, if acidity is increased too much, it can result in hydrolysis of the epoxy 
ring to the corresponding diol being prevalent reaction, which limits the nucleophile 
attack. Precipitation process is most prevalent in basic conditions, which leads to epoxy 
rings remaining closed. The optimization of these reactions would need careful 
considerations of the reaction times and pH values present in hybrid synthesis (Gabrielli, 
Russo et al. 2013) 
 
3.4 Current state of hybrid biomaterial research 
 
The synthesis of the first organic-inorganic hybrids traces all the way back to early 1980s, 
more commonly referred to as “organically modified silicates” or “ormosiles” (Jones 
2012) In these hybrids starting materials were often polydimethylsiloxane (PDMS) or also 
currently widely used tetraethyl orthosilicate (TEOS). More modern approach to hybrids 
is to focus on covalently coupled class II hybrids (Table 1).  
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Organic 
phase 
Inorganic Phase Coupling 
agents 
Cells Scaffold 
fabrication 
Reference 
Gelatin SiO2-Ca(NO3)2 GPTMS MSCs freeze-
drying 
(Mahony, Tsigkou et al. 
2010) 
Gelatin SiO2 - CaO GPTMS L929 mouse 
fibroblasts 
microsphere 
leaching 
(Lao, Dieudonné et al. 
2016) 
γPGA* SiO2 GPTMS osteosarcoma foaming (Poologasundarampillai, 
Ionescu et al. 2010, 
Poologasundarampillai, 
Yu et al. 2012) 
chitosan SiO2 GPTMS - freeze-
drying 
(Shirosaki, Tsuru et al. 
2009) 
PEG SiO2 ICPTES SAOS2 rapid 
prototyping 
(Hendrikx, Kascholke et 
al. 2016) 
PCL*, 
Poly(VP-
co-
TEVS)  
borophosphosilicate 
glass 
GPTMS MC3T3-E1 compression 
molding, salt 
leaching 
(Mondal 2018) 
* poly-γ-glutamic acid (γPGA), polycaprolactone (PCL), N-vinylpyrrolidone (VP), 
triethoxyvinylsilane (TEVS)  
 
Unquestionably the most common hybrid combination so far includes silica-gelatin 
hybrids prepared by sol-gel -route. (Ren, Tsuru et al. 2001, Mahony, Tsigkou et al. 2010, 
Mahony, Yue et al. 2014, Lao, Dieudonné et al. 2016). As seen from the Table 1, hybrids 
have been mainly synthesized by using TEOS as the inorganic sol gel precursor instead 
of melt-quenched BAG particles. However, many different organic polymers are found to 
be suitable to couple with a coupling agent, such as gelatin, chitosan and 
polycaprolactone (PCL).  
However, due to the challenging nature of hybrid synthesis chemistry, and several issues 
in hybrid composition optimization, such as the choice of the coupling agent, there is still 
a long way to release the full potential of hybrid biomaterials.  
Table 1. Selected class II hybrids for bone tissue engineering applications 
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4. RHEOLOGY 
Rheology is the deformation and flow behaviour of materials. Literally the meaning of 
rheology is “flow science”: the term “rheology” originates from the Greek word “rheos”, 
meaning “river”, “flowing” or “streaming”. (Mezger 2012) It is dependent on the material’s 
inner structure, the outside forces stressing the material, and finally the ambient 
conditions, such as surrounding temperature.  
In the context of hybrid materials rheology is interesting due to the viscoelastic nature of 
the material. By studying rheological properties of hybrids, important information about 
its gelation as a function of time or temperature could be assessed. These properties are 
essential for example when designing bioinks for extrusion-based bioprinting, which is a 
popular scaffold preparation method. (Ozbolat, Hospodiuk 2016) 
Rheological behaviour of a material can be classified as shown in Table 2 below: 
(Mezger 2012) 
LIQUIDS SOLIDS 
ideally viscous viscoelastic viscoelastic ideally elastic 
flow behaviour flow behaviour deformation 
behaviour 
deformation 
behaviour 
flow/viscosity curves creep tests, relaxation tests, oscillatory tests 
 
4.1 Oscillatory measurements and detection of gel point 
Oscillation measurements, where the plate system oscillates instead of rotation, are used 
because, in this way, more viscous samples are not destroyed too easily and can be 
studied. In addition, with oscillation, it is possible to measure materials within their linear 
viscoelastic range (LVE), which indicates the range in which the test can be carried out 
without destroying the structure of the sample. (Murata 2012) 
In the two-plate model the upper plate is moving, while the lower plate remains 
stationary. The sample is sandwiched between these plates to study its deformation 
behaviour (Fig. 15).  
Table 2. Classification of rheological behaviour 
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Figure 15. Two-plate system with 20 mm diameter plate geometry 
 
Shear modulus G can be express as: 
 
𝐺 =  
𝜏
𝛾
    (1) 
where τ is the shear stress and γ is the shear deformation / shear strain. Shear modulus 
G describes the material’s strength or stiffness, and it is influenced by time and 
temperature. Shear stress can be defined as: 
𝜏 =  
𝐹
𝐴
       (2) 
where F is the shear force applied to stressed material, and A is the area of the upper 
plate. Unit of shear stress is [N/m2] or [Pa]. Shear deformation can be defined as: 
𝛾 =  
𝑠
ℎ
    (3) 
where s is the deflection path from rest to maximum deflection, and h is the distance 
between plates.  
Oscillation frequency can be specified either as angular frequency ω in [rad/s] or as the 
frequency f in [Hz]. These two can be conversed to each other as follow:  
 
ω = 2π ∙ f   (4) 
 
Viscoelastic material can be described by 1) their storage modulus and 2) their loss 
modulus.  
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Complex shear modulus G* [Pa] is used since values that are determined in harmonic 
periodic fashion in sinusoidal processes like oscillation are written in complex form: 
𝐺∗ =  
𝜏𝐴
𝛾𝐴
   (5) 
 
Storage modulus G’ (G prime) stands for the stored deformation energy by the sample 
during deformation process, such as shearing. Materials which store deformation energy 
ultimately stay in unchanged shape after a load cycle. Therefore, G’ measures the elastic 
behaviour of the sample.  
Loss modulus G’’ (G double prime) measures the lost deformation energy during 
deformation. In other words, the structure of the material changes, and energy is spent 
during the process. Materials that behave that way include samples that flow either 
partially or completely. With flow there is relative motion between the units of the 
structure, which causes frictional forces between the components. Ultimately, frictional 
heat is created. A part of this heat energy heats up the sample, and another part may be 
lost in the form of heat to the surrounding environment. Irreversible deformation 
behaviour occurs, and therefore, G’’ measures the viscous behaviour of the sample. 
(Mezger 2012, Murata 2012) 
The relationship between G*, G’ and G’’ using phase-shift angle δ can be seen in Figure 
16:  
 
Figure 16. The relationship between G*, G’ and G’’ using phase-shift 
angle δ 
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From this figure we get: 
tan 𝛿 =  
𝐺′′
𝐺′
   (6) 
 
This is referred to as the loss factor, which is a measure of the lost and stored 
deformation energy. This way the ratio of the viscous and elastic portion of the 
viscoelastic deformation behaviour can be defined. For instance, ideal elastic behaviour 
happens when tan 𝛿 = 0, and G’ dominates G’’. Correspondingly, ideally viscous 
behaviour is expressed as tan 𝛿 → ∞, where G’’ completely takes over G’. (Mezger 2012) 
In the case of gel formation, hardening and curing processes, sol/gel transition point (gel 
point) is reached when tan 𝛿 = 1, and the ratio of G’ and G’’ is the same. (Fig. 17) 
 
Figure 17. Sol/gel transition point (gel point) 
 
 
In general, the relationship between G’ and G’’ is summarized below: 
 
 G’ < G’’, viscoelastic liquids 
 
 G’ = G’’, sol-gel transition point, gel point 
 
 G’ > G’’, viscoelastic solids 
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4.2 Temperature-dependent flow behaviour  
 
The effect of temperature on the flow and deformation behaviour of measured sample 
can be assessed with rheological temperature ramp measurements. In these 
measurements, viscosity η is determined as a function of the temperature. For example, 
it is possible to investigate the softening/melting temperature, or solidification 
temperature of the sample by this type of rheological measurement. Viscosity can be 
defined for ideally viscous liquids at a constant temperature as: 
η =  
𝜏
𝛾
   (7) 
where τ is the shear stress, and γ is the corresponding shear rate. Unit of viscosity is 
[Pas] (Pascal seconds, 1 Ns/m2).  
 
Figure 18. Viscosity as a function of temperature 
 
As seen in Figure 18, the temperature is commonly represented on a linear scale on the 
x-axis of η(T) –diagram, having viscosity as y-axis either on linear or logarithmic scale, 
depending on the range of viscosity values measured. ηmin shows the viscosity minimum 
and it is called softening or melting temperature. ηmin shows the viscosity maximum 
usually giving information about the crystallization or freezing point of the sample. 
(Mezger 2012) 
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5. MATERIALS AND METHODS 
The objective of the study was to synthesize two different bioactive glass/gelatin hybrid 
materials and characterize their in vitro dissolution properties and biocompatibility using 
human bone marrow derived mesenchymal stem cells (hBMSCs).   
The experimental part of the work was conducted as a cooperation between the 
Bioceramics, -glasses and –composites group, and the Adult Stem Cell group at 
Tampere University.  
5.1 Materials 
Two bioactive glass compositions were used in hybrid synthesis: commercially available 
S53P4 (BonAlive®) as a control and a borosilicate glass, based on the S53P4, where 
12.5% of the SiO2 was replaced with B2O3,and CaO was partly substituted with Sr and 
Mg (labelled “mix”/BMgSr)  (Tainio 2016). The glasses were melted, in air, at 1400 and 
1200 °C, respectively. They were they annealed at 520 and 500 °C respectively to 
remove residual stress and further crushed to obtained powder, using a ball mill. The 
particle size used was < 38 µm. Both BAGs were made at the laboratory of tissue 
engineering and biomaterials, and the full protocol can be found elsewhere (Tainio, 
Salazar et al. 2020). The compositions (in mol%) of both glass compositions are shown 
in Table 3 below: 
 SiO2 B2O3 CaO Na2O P2O5 MgO SrO 
mix 47.12 6.73 6.77 22.66 1.72 5.00 10.00 
S53P4 53.85 - 21.77 22.66 1.72 - - 
 
In addition to bioactive glass, gelatin from porcine skin (Type A 300, Sigma) was used 
along with 3-Glycidyloxypropyl trimethoxysilane (GPTMS) (Sigma), and 0.01 M 
hydrochloric acid (HCl) diluted from 1M Titripur Reag. Ph Eur, Reag. USP (Sigma). 
Hybrids were prepared by first dissolving gelatin into 0.01 M HCl at 50 mg/ml 
concentration, at 37 °C. GPTMS (v = 3.68 ml) and bioactive glass (m = 535,7 mg) were 
added simultaneously to match the C-factor 1000, and the final solution was left to rotate 
in a UVP Hybridizer Hybridization oven (Analytik Jena US LLC, California, USA) until 
gelation. The protocol is summarized in the Figure 19 below:  
Table 3. Used bioactive glass compositions in mol-% 
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Figure 19. Synthesis protocol for hybrids 
 
In this study the C-factor (CF), which is referred to as the molar ratio between GPTMS 
and gelatin (
𝐺𝑃𝑇𝑀𝑆 (𝑚𝑜𝑙)
𝑔𝑒𝑙𝑎𝑡𝑖𝑛 (𝑚𝑜𝑙)
), was maintained constant at 1000. 
Various weight ratios of gelatin and BAG were tested. The weight ratio was found to 
influence the gelation time. Times before gelation in the hybridizer are reported in the 
Table 4. Gelation time was assumed to be from the time of mixing all the reagents to 
complete gelation of hybrid into solid gel. For the composition 30/70 rheological 
properties were measured. In this case the hybrid gels were not let to completely gelate, 
but instead after visible increase of viscosity (transforming from liquid to honey-like 
consistency) rotation was stopped.  
 
 
Full gelation time Rheological 
measurements 
S53P4/gelatin 30/70 
15/85 
5/95 
1/99 
~4h 
~6h 
~12h 
~24h 
~3h 30 min 
- 
- 
- 
mix/gelatin 30/70 
15/85 
5/95 
1/99 
~1h 30 min 
~4h 
~6h 
~11h 
~1h 15 min 
- 
- 
- 
Table 4. Gelation times for hybrids 
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5.2 Methods 
5.2.1 In vitro dissolution 
 
Dissolution test for hybrid materials were performed in simulated body fluid (SBF), which 
has similar ion concentration to blood plasma (Table 5). SBF test is used to assess the 
ability of the material to induce precipitation of hydroxyapatite layer (bioactivity). In 
addition, hybrid dissolution was also tested in collagenase (enzymatic degradation) 
solution. SBF buffer solution was prepared following the protocol presented by Kokubo 
et al (Kokubo, Kushitani et al. 1990). Specific details about SBF preparation is presented 
in the Appendix. 
 
 Na+ K+ Mg2+ Ca2+ Cl- HCO3- HPO42- SO42- 
Plasma 142.0 5.0 1.5 2.5 103.0 27.0 1.0 0.5 
SBF 142.0 5.0 1.5 2.5 147.8 4.2 1.0 0.5 
 
Hybrids were synthesized for SBF dissolution test according to the protocol described 
earlier. The following day after synthesis gels were cut into small pieces ranging from 
450 mg to 510 mg. Sample pieces were placed into 30 ml falcon tubes. The solution to 
mass ratio was kept constant at 1mL/35mg. The time points for SBF test included 24, 
48, 72, 168, and 336 hours. All the measurements were done in triplicates except SBF 
controls without hybrid samples. SBF dissolution samples were kept between time points 
in Multitron AJ 188g (Infors, Bottmingen, Switzerland) shaking incubator at 37 °C and 
100 RPM.  
At each time point pH values of each SBF solution were measured at 37.00 ± 0.02 °C 
with Mettler Toledo SevenMulti MP 225 pH-meter (Mettler-Toledo International Inc., 
Greifensee, Switzerland) From the extracted solution the ion concentrations were 
analysed with Inductively coupled plasma optical emission spectrometry (ICP-OES) 
(Agilent Technologies, California, USA). Samples for ICP-OES were prepared by diluting 
the samples 10 times to 1M nitric acid (HNO3). The analysed wavelengths are listed in 
the table below: 
Table 5. Ion concentrations of blood plasma and SBF buffer solution (mmol/l) 
(Varila, Fagerlund et al. 2012) 
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 B Ca Mg Na P Si Sr 
Wavelength 
(nm) 
249.772 396.847 285.213 589.592 213.618 288.158 407.771 
 
 
In addition, mass loss of the immersed hybrid pieces was calculated:  
 
𝑚𝑎𝑠𝑠 𝑙𝑜𝑠𝑠 =  
𝑚0−𝑚1
𝑚0
 ∙ 100 %  (8) 
 
Before weighing the sample pieces were washed with 96% ethanol to remove excess 
SBF and dried gently with paper.  
The collagenase degradation test was conducted for 0.5h, 1h, 2h, 3h, 4h, 5h, and 6h. 
Hybrid gels were synthesized similarly as for the SBF dissolution test. The following day 
after synthesis gels where cut in small pieces (300-380 mg) in order to fit into 48 well 
plates. All measurements were done in triplicates, and between time points samples 
were left in 48 well plate in physiological temperature 37 °C inside incubator.  
 0.1% collagenase solution was prepared by mixing collagenase enzyme (from 
Clostridium histolyticum, type IA, crude, Sigma), TRIS-HCl (50 mM) and CaCl2 (0,36 mM) 
into distilled water. After dissolving all the reagents, the pH value was adjusted to 7.4 at 
37 °C by adding drops of 1M NaOH. Collagenase solution was added to wells with 
samples to match ratio of 1000 mg of sample per 3 ml. At every time point ICP-OES 
samples were prepared similarly as for the SBF samples. In addition, mass loss was 
calculated by using the equation (8) defined earlier.  
 
5.2.2 Thermogravimetric analysis (TGA)  
 
In order to analyse the glass and gelatin distribution of the hybrid materials 
thermogravimetric analysis (TGA) was conducted. STA 449 F1 Jupiter Simultaneous 
Thermal Analyzer (Netzsch Group, Selb, Germany) was used in measurements with 
Al2O3 crucibles. For both hybrids, small pieces of overnight stabilized gels were cut and 
left to dry in room temperature for 48 hours. In addition to time point 0 h samples, TGA 
analysis was also conducted to samples being immersed in SBF for 24, 48, 72, and 168 
hours. Also, gels consisting of only gelatin and GPTMS were prepared and dried 24 
hours, and then analysed. All measurements were done in triplicates. The TGA analysis 
Table 6. Wavelengths for ICP-OES 
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was conducted from room temperature to 600°C at 5K/min, in air. The organic content 
burns during heating and the inorganic glass part is left as residue.  
 
 
5.2.3 Rheological measurements 
 
In order to study the viscoelasticity of the hybrids rheological measurements were 
conducted. Rheological measurements were performed using Discovery Series Hybrid 
Rheometer 2 (TA Instruments, Delaware, USA) using 20 mm diameter parallel plate 
geometry. 
Two different procedures were used: time sweep and temperature ramp. Timesweep 
measurements were performed at 37 °C for 1.5 h, with 20 mm diameter parallel plate 
geometry, and sample size of 350 µl. The mixing time inside hybridizer was 1 hour 15 
minutes for mix hybrids, and 3 hours 30 minutes for S53P4 hybrids. These mixing times 
were chosen based on the visible viscosity increase of the hybrids, which is needed in 
order to be able to pipette samples and sandwich them between parallel plates. These 
mixing times were kept constant for each measurement. The moduli G’ and G’’ were 
detected at frequency of 1.0 Hz and 0.1% strain.  
Temperature ramps were performed with temperatures ranging from 37 °C to 20 (18) °C, 
with 300s soak time at 37 °C, and ramp rate 0.5 °C /min. 20 mm diameter parallel plate 
geometry was used, with hybrid sample size of 350 µl. The samples for temperature 
ramps were prepared without adding coupling agent GPTMS, because it would cause 
gelation time-dependently, and therefore the real impact of the temperature on gelation 
would not be able to be studied. For this reason, 25 ml of 0.01 M HCl and 535,7 mg of 
BAG were mixed and rotated in hybridizer in 24 °C until visible increase of viscosity (1,5 
hours for mix hybrid and 2 hours for S53P4 hybrid).  
For all the measurements the upper plate of the parallel plate system was lowered until 
it was in contact with the sample surface and axial force on the instrument was 0.01 N. 
All measurements were conducted in triplicates.  
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5.2.4 Hybrid cytotoxicity testing  
 
In the cell culturing part of this thesis work, the cells used were human bone marrow 
derived stem cells (hBMSCs), passages ranging from four to six. Used medium included 
5% human serum (HS) and 1% of penicillin – streptomycin (P/S) antibiotics. The medium 
was sterile filtered using Stericup (Thermo Scientific Nalgene Rapid-Flow) before using 
in contact with cells to minimize the risk of contamination. Growth factor FGF-2 was 
added to culturing flasks (Biolite 75 cm2 flasks and 25 cm2 flasks, vented, Thermo 
Scientific) 5µl per 75cm2 flask when expanding the cells. Adding FGF-2 has shown to 
enhance osteogenic potential, extend cells’ lifespan and proliferative capacity. (Bianchi, 
Banfi et al. 2003, Martin, Muraglia et al. 1997) All the Live/Dead experiments were 
conducted in Nunclon delta surface (Thermo Scientific) wellplates. 
All cell culturing and testing was performed in CellTech Laboratory and BMT laboratory 
at the Institute of Biosciences and Medical Technology (BioMediTech, Arvo building). 
Cryopreserved human bone marrow derived mesenchymal stem cells (passages 4-6) 
were thawed according to instructions provided by Adult Stem Cell Group. Melted cell 
suspension was added into 5 ml of cold medium and centrifuged for 5 min 1000 rpm 
(Eppendorf centrifuge 5810 R, Eppendorf Ag, Germany). Cell pellet was then 
resuspended in 4 ml of warm medium and divided to two 75 cm2 cell culturing flasks. 
(Flasks 2 ml + 8 ml medium inside). In addition, 5 µl of FGF-2 growth factor (10µg/ml) 
were added to both flasks. Flasks were left in the incubator at 37°C, and medium were 
changed every three days. 
The general rule when culturing BMSCs is to seed 3000 cells per cm2, which means 
approximately 225 000 cells per 75 cm2 flask. When increase in proliferation rate is 
wanted, medium is changed only partially, and new FGF-2 is added only half the amount 
of usual (2.5 µl). It is also possible to slow down the proliferation by changing the whole 
medium.  
When cells reach ~80% confluency, they were trypsinized (TrypLE Select 1X, 
ThermoFischer) according to given protocol, and counted using Bürker cell counting 
chamber. Seeding density was 25 000 cells per 1 cm2 (per well in 48-well plate), so after 
counting cells were suspended to medium to match 25 000 cells/ml.  
hBMSCs were seeded to 11mm diameter and ~3mm thickness cylinder-shaped samples 
(Fig 20). 
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Figure 20. Hybrid sample for cell cultures, diameter 11 mm, height 
3mm 
 
The hybrids for the cell samples were synthesized the way explained earlier, but all the 
reagents were sterile-filtered, and synthesis was conducted inside a laminar hood. 
Hybrids were rotated in hybridizer oven until preferred viscosity was reached, then they 
were casted into cut syringe moulds, and covered with autoclaved aluminium foil caps 
(Fig. 21). This way it was possible to ensure uniform size of the samples, and the 
samples were found to easily detach from syringes without breaking. For example, when 
casted directly to well plates, it was impossible to get samples out without breaking them.  
 
 
Figure 21. Syringe moulds with autoclaved aluminium foil caps 
 
The moulds were let in room temperature inside laminar hood, and they were cut with 
11mm diameter hollow puncher the next day.  
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Figure 22. 11mm diameter cylinder-shaped samples fit perfectly in 48 
well plates 
 
Pre-incubation of the samples was performed in cell culturing medium for minimum 72 
hours, in 37°C incubator. This way the initial burst release of ions can occur without cells, 
and it would wash away unreacted molecules.  
Live/dead viability/cytotoxicity assay was used to detect cell proliferation and viability at 
time points 24h, 72h and 168h according to the instructions provided by the Adult Stem 
Cell Group. The Live/Dead working solution was prepared in concentration earlier 
optimized for well plates and bioactive glass scaffolds, summarized in Table 7 below:  
 
Dye Working 
concentration 
Pipette 
Dye DPBS 
EthD-1 0,25 µM 1,25 µl 10 ml 
Calcein AM 0,50 µM 1,25 µl 
 
 
-20 oC stored dyes are warmed to room temperature and pipetted into Dulbecco's 
phosphate-buffered saline (DPBS). Wells to be analysed are first washed once with 
warm DPBS, and then working solution is added for 30-45 minutes. Wellplates are 
covered with an aluminium foil for protection against light. After incubation working 
solution is removed and DPBS added for visualization. Dead control is prepared by 
adding 1 % Triton-X to cells and incubating for 10 minutes in room temperature.  
Microscopy of the stained samples was done using Olympus IX51 Inverted Fluorescence 
microscope, and by using the software DP Controller (2.2.1.227) and DP Manager 
Table 7. The protocol to prepare Live/dead working solution 
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(2.2.1.195). (IX51, Olympus, Tokyo, Japan, equipped with a fluorescence unit and a 
camera DP30BW, Olympus). When visualizing the blue filter is for living cells stained by 
Calcein AM, and the green filter is for necrotic cells stained by EthD-1. Images were 
treated using ImageJ software. The overall cell culturing method is summarized below in 
Figure 23:  
 
 
Figure 23. Protocol for cell culturing, direct method 
 
Cells were cultured also using other method. In order to assess the effect of degradation 
byproducts from hybrids to cells, cells were cultured also in contact with preincubation 
medium without actual hybrid sample pieces. From pre-incubation immersion medium is 
collected from different time points and already seeded cells are cultured with this 
immersion medium. This is shown in the Figure 24: 
 
 
Figure 24. Protocol for cell culturing, indirect method  
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From both methods ICP- samples were collected in 15 ml falcon tubes and diluted to 
distilled water in ratio of 1:10. ICP samples were stored in freezer until ICP-OES analysis. 
The wavelengths presented in Table 6 earlier were also used for these ICP samples. 
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6. RESULTS  
6.1 pH measurements 
pH – values of hybrids during their synthesis were measured in order to assess pH value 
changes during the gelation process. Table 8 presents approximate pH values during 
hybrid synthesis process for both hybrids. All pH-values were measured at 37.00 ± 0.02 
°C, except the measurements with pH-paper. Due to different gelation times and 
changes in viscosity of hybrid solutions pH values were measured at different times.  
 
 
S53P4 30/70 mix 30/70 
Directly after mixing pH-paper 
pH meter 
8 
7.64 ± 0.02 
9 
8.54 ± 0.02 
0.5h-1h in rotation, no 
visible change in viscosity 
pH paper 
pH meter 
8 
8.29 ± 0.02 
10 
9.07 ± 0.02 
Increasing viscosity pH-paper 
pH meter 
9 
8.56 ± 0.02 
10 
9.43 ± 0.02 
After overnight 
stabilization (fully gelated) 
pH paper 
pH meter 
9 
- 
10 
- 
 
 
For both hybrids, the pH value was observed to increase during synthesis. For mix 
(borosilicate) hybrid pH values were slightly higher. However, due to increasing viscosity 
of hybrids in synthesis there is no information whether the pH keeps rising during and 
after gel point.  
 
6.2 Thermogravimetric (TGA) analysis 
 
TGA analysis was conducted to assess the hybrid resistance to thermal decomposition 
and to evidence successful grafting of GPTMS to gelatin and BAG. Thermal 
decomposition of BAG/gelatin hybrid consists of two steps: first the decomposition of 
organic gelatin in lower temperatures, and finally of BAG in very high temperatures. 
Table 8. pH-values of 30/70 hybrids during synthesis 
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Organic-inorganic crosslinking would result in higher resistance to thermal 
decomposition. (Lao, Dieudonné et al. 2016) In our case, only decomposition of gelatin 
was assessed, and therefore temperature was raised only until 600 °C. This way we can 
assess whether our hybrids in reality display the theoretical 30/70 weight ratio between 
bioactive glass and gelatin.  
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Figure 25. Residual mass of S53P4 & borosilicate (mix) hybrids 
compared to gelatin/GPTMS  
 
Residual masses of both hybrids and gel made of only gelatin and GPTMS are shown in 
Figure 25. Higher residual mass for hybrids indicate higher resistance towards 
dissolution and slightly improved stability. However, differences are relatively small.  
For triplicates combined values are displayed in Table 9 below using standard deviation 
to calculate error:  
 
 Residual mass (%) at 600 °C 
Gelatin & GPTMS 51.89 
S53P4 54.73 ± 1.24 
mix 53.44 ± 1.22 
 
Table 9. Residual masses of S53P4 and mix hybrids 
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By using the measured residual masses, it is possible to calculate back and estimate the 
weight ratio between BAG, gelatin and GPTMS.  
 
residual mass at 600 °C, gelatin & GPTMS(1 - x) + x = residual mass at 600 °C (hybrid)   
 
x = percentage of BAG remaining 
 
Using this formula percentages of S53P4 and mix can be calculated:  
• S53P4 ~6% 
• B12,5-Mg5-Sr10 ~2% 
 
The calculated values represent the hybrid composition quite accurately. Because the 
theoretical composition of 30/70 wt-% between BAG and gelatin didn’t take account the 
mass of added GPTMS, the real amount of BAG is much less than theoretical 30 %. The 
density of GPTMS being 1.07 g/ml at 25 °C, it can be estimated that the more realistic 
weight ratio would be ~69% of GPTMS, ~22% of gelatin, and ~9% of BAG. 
 
6.3 In vitro dissolution 
From the SBF dissolution firstly the pH changes of different hybrid compositions were 
studied (Fig 26). Error stated by the pH- meter manufacturer (± 0.02) was used, unless 
the error measured from triplicates was bigger. In that case, the error was stated as the 
standard deviations of the triplicates.  
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Figure 26. pH value changes in SBF immersion for 2 weeks 
 
As seen in Figure 26, in general, higher glass content leads to higher pH increase. 
Clearly for 30/70 hybrids pH increased the most, while other compositions containing 
less BAG showed more subtle pH increase. pH can be seen to increase most rapidly 
during the first 72 hours in SBF immersion, and to stabilize at 2 weeks of immersion.  
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Figure 27. Mass loss (%) upon dissolution in SBF for up to 2 weeks 
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As seen in Figure 27, all hybrids showed mass loss upon immersion in SBF. Regardless 
of the glass/gelatin ratio the mass loss was rapid for up to 24h, then slowed down up to 
72h and finally was fairly stable until 2 weeks. The mass loss was more pronounced in 
materials with higher glass content and more subtle for the materials containing less 
glass particles. The mass loss was also found to be significantly higher for hybrids 
containing the silicate glass compared to the one (with similar glass content) containing 
the borosilicate bioactive glass.  
In addition to pH and mass loss, Si, B, P, Ca, Mg and Sr ion release patterns from hybrids 
were determined with ICP-OES measurement (Fig. 28-30). 
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Figure 28. Si concentration in SBF immersion as a function of 
immersion time 
 
All hybrid compositions show increasing amount of Si in solution as a function of 
immersion time. The quantity of released Si was higher in the case of silicate bioactive 
glasses than for the borosilicate counterpart. Furthermore, it is important to note that the 
Si release was highest for the 5/95 hybrids, and lowest for 30/70 hybrids. This indicates 
that the higher the glass content the lower the Si release in solution. 
Figure 28 and 29 presents the Ca and P concentration, respectively, in the solution as a 
function of immersion time.  
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Figure 29. Ca concentration in SBF immersion as a function of 
immersion time 
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Figure 30. P concentration in SBF immersion as a function of 
immersion time  
 
Before discussing the Ca release, it is important to remind that the mix glass contains Sr 
and Mg which were replaced for Ca. Therefore, in the mix glass the Ca content is 
significantly lower than for the S53P4 glass. 
With increasing immersion time, the Ca content remained fairly constant in the case of 
the hybrid containing S53P4 in 30/70 ratio. The hybrid containing similar glass content 
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but of the borosilicate glass the Ca content decrease at 2 weeks of immersion. All other 
samples exhibit a decrease in the Ca content starting between 24 and 72 h of immersion 
depending on the materials compositions. 
The P concentration, however, showed a significant decrease in concentration, for all 
materials with increasing immersion time, already at 24h of immersion, except for the 
5/95 samples that exhibit a decrease in P at longer time. In general, the higher the glass 
content the more rapid the drop in P. Also, the silicate glass leads to faster decrease in 
P. For all hybrid compositions both Ca and P concentrations decreased in 2 weeks of 
SBF immersion, indicating HCA layer formation on BAG surface.  
In addition, thermogravimetric analysis for post-SBF immersion hybrids was conducted.  
This would give information about the effect of SBF immersion on the stability of the 
hybrids. Figure 31 presents the TGA curves from hybrids made using mix glass, after 
synthesis (t=0h) and after immersion in SBF (t=24, 48, 72, 168h). 
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Figure 31. Residual mass of borosilicate hybrids (mix) before (t=0h) 
and after SBF immersion (24h) 
 
First of all, once can notice that the shape of the curve, post immersion resembles more 
the TGA curve of the gelatin/GPTMS without bioactive glass presented in Figure 25. 
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For borosilicate hybrids it can be seen that hybrid before SBF immersion is slightly more 
stable than same hybrids after immersion. This is detected by observing the shape of 
the curve compared to later time points, mass loss upon heating is detected to be slightly 
slower. No big differences between the SBF immersion hybrids is detected, their 
behavior upon heating is very similar, with similar amount of residual mass after heating 
to maximum temperature.  
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Figure 32. Residual mass of S53P4 hybrids (mix) before (t=0h) and 
after SBF immersion (24h) 
 
As seen in Figure 32, S53P4 hybrids seem slightly more reactive in terms of the bioactive 
glass: the residual mass decreases upon SBF immersion time more than when 
compared to mix hybrids. S53P4 hybrids are probably also slightly more resistant against 
heating, because there is no as big difference between the behaviour of hybrid before 
and after SBF immersion.  
For triplicates combined values are displayed in Table 10 below using standard deviation 
to calculate error:  
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 SBF immersion time (h) Residual mass (%) at 600 °C 
S53P4 24 59.96 ± 0.62 
 48 50.70 ± 3.61 
 72 51.11 ± 2.06 
 168 50.26 ± 0.72 
mix 24 55.42 ± 0.19 
 48 53.77 ± 0.58 
 72 53.64 ± 1.23 
 168 54.25 ± 0.53 
 
The residual masses are slightly larger for mix hybrids, but overall no big differences 
between two hybrids in terms of the residual mass as a function of immersion time. 
Overall, the residual mass decreases upon SBF immersion. 
In vitro enzymatic studies are aimed at assessing the potential increased in stability, 
upon enzymatic attack, of the hybrids. In turn, this can give insight on the level of cross-
linking between the organic and inorganic phase. Two different hybrid materials with 
same weight ratio of gelatin and glass (30/70) but different BAG, were studied to assess 
how hybrid composition alters the enzymatic degradation behaviour. This was analysed 
by measuring the mass loss of collagenase solution immersed hybrid samples, and by 
analysing their ion release by ICP-OES. Errors are stated as standard deviation, and all 
experiment is performed with three parallel samples.  
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Figure 33. Enzymatic degradation of hybrid materials by collagenase, 
mass loss in % 
 
Table 10. Combined residual masses after SBF immersion 
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Both hybrids degraded rapidly in collagenase solution immersion, as expected due to 
the high gelatin content of the hybrids. After one-hour immersion in collagenase solution 
mass loss of sample pieces were found to be over 50%. After three-hour immersion all 
samples were completely dissolved in collagenase solution. However, compared to plain 
gelatin, adding of GPTMS and BAG resulted in more stable gels.  
From ICP-OES results (Fig. 34) it can be seen that the Si release increases until three 
hours for both hybrids, and after that all samples completely dissolved in solution. Clearly 
Si-O-Si bonds are undergoing destruction. In S53P4 composition there is slightly more 
Si, which explains higher Si release. Otherwise both hybrids have same C-factor, and 
both completely dissolved, so only reason for difference is the difference in glass 
composition.  
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Figure 34. Si release during enzymatic degradation 
 
Results for all ions individually are presented in Appendix.  
 
 
 
 
6.4 Rheological properties 
Rheological properties of hybrids were assessed in order to evaluate the gel point and 
other viscoelastic properties of the hybrids. Both hybrids in BAG/gelatin ratio 30/70 were 
49 
 
characterized through oscillatory time sweeps at 37 °C and through temperature ramps. 
Hybrids were mixed inside hybridizer until few minutes before expected gelation. 
Expected gelation time was possible to estimate from the visible increase in viscosity of 
the gels. Mixing time and the initiation time for rheological measurements was kept same 
for every measurement.  
The G’ and G’’ moduli as a function of time for the 30/70 mix hybrid can be seen in Figure 
35 below: 
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Figure 35. G’ and G’’ as a function of time for 30/70 mix hybrid 
 
For borosilicate hybrid (mix) gelation point, where the moduli intersect, is detected 
approximately around 800 seconds. When the initial mixing time of 1h 15min is 
considered the overall gelation time for mix hybrid is estimated around 1h 30 min. Similar 
result is shown in Table 4. After gelation point both moduli can be seen to continue 
increasing.  
The G’ and G’’ moduli as a function of time for the 30/70 S53P4 hybrid can be seen in 
Figure 36 below: 
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Figure 36. G’ and G’’ as a function of time for 30/70 S53P4 hybrid  
 
For S53P4 hybrid similar behaviour in terms of gelation is detected. However, the time 
window between viscosity that is possible to use as time sweep sample, and full gelation 
point is slightly shorter than for borosilicate hybrid, less than 500 seconds. When the 
mixing time of 3h 30 min is considered, overall gelation time of approximately 3h 40 min 
is obtained. This slightly less than earlier measured 4h shown in Table 4. In addition, 
similarly than for mix hybrid, for S53P4 hybrid the both moduli keep increasing after the 
detected gelation point. 
In addition to gelation point detection in means of time sweep measurements, 
temperature ramps for both hybrids without adding time dependent GPTMS are 
performed (Fig. 37). Gel containing only gelatin is used as a control.   
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Figure 37. Viscosity as a function of temperature for hybrids, gelatin as 
a control 
 
As seen in Figure 37, for all the materials the viscosity increases as a function of 
decreasing temperature. This indicates the gels becoming more solid in lower 
temperatures. S53P4 hybrid follows similar pattern in viscosity increase as a function of 
decreasing temperature than control gelatin. For borosilicate hybrid the viscosity 
increase is steeper and occurs earlier in slightly higher temperature (~24 °C).  
 
6.5 Hybrid cytotoxicity  
 
The biocompatibility of hybrid materials was assessed by culturing human bone marrow-
derived stem cells (hBMSCs) in contact with hybrid materials. In addition, hBMSCs were 
cultured with hybrid extract, without direct contact with the samples.  
Images from Live/Dead assay for 15/85, 5/95, and 1/99 wt-% compositions (BAG/gelatin) 
for both hybrids are seen below:  
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Figure 38. hBMSC viability in contact with hybrid materials. Scale bar 
200 µm. 
 
As seen in Figure 38, after 24h of culturing some elongated and attached cells can be 
seen for each composition, except for 1/99 wt% hybrids. However, after 72 hours, cell 
proliferation and attachment deteriorate rapidly, resulting in very low viability of hBMSCs. 
No big difference between the borosilicate or S53P4 glass is observed in terms of cell 
viability. 
Similar results were received from imaging cells in contact with hybrid extracts, without 
contact with the material. Naturally when hBMSCs were already spread and attached to 
well plates, more viable cells are detected in images.  
 
 
Figure 39. hBMSC viability when cultured with hybrid extracts. Scale 
bar 200 µm.  
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For all other composition than S53P34 1/99 wt-%, decrease in cell proliferation and 
attachment is detected already with 24h immersion extract. This is seen as changes in 
cell morphology and clear areas on the well plate, where attachment is lost.  
In addition to Live/Dead assay, the ion release from hybrids during pre-incubation phase 
and during cell culturing when immersed in cell culturing medium was also studied with 
ICP-OES.  
 
 
 Overall the measured ion concentrations after 72h pre-incubation are much higher 
than ion concentrations measured from cell cultures after pre-incubation (Fig. 40-44).  
Especially Si concentrations are much higher also when compared to ICP-OES results 
from SBF dissolution test (Fig. 28)  
ICP-OES results from cell cultures at certain time points are shown below: (Fig. 40-44). 
 
.  
  
Table 11. Ion concentrations (µg/ml) after 72h pre-incubation in medium 
 
S53P4 15/85 mix 15/85 S53P4 5/95 mix 5/95 
 
S53P4 1/99 
 
mix 1/99 
B - 41.23 ± 
3.27 
- 11.17 ± 
2.23 
- 4.20± 
0.50 
Ca 147.40 ± 
20.85 
66.53 ± 
11.14 
58.17 ± 
8.43 
66.50 ± 
9.20 
64.73 ± 
4.13 
84.25 ± 
0.49 
Mg 14.03 ± 
2.25 
40.70 ± 
2.00 
13.70 ± 
3.50 
23.87 ± 
2.12 
13.50 ± 
2.50 
18.34 ± 
1.85 
P 10.97 ± 
0.81 
14.90 ± 
5.67 
17.97 ± 
1.33 
33.60 ± 
3.63 
30.53 ± 
1.70 
37.03 ± 
6.44 
Si 483.12 ± 
29.44 
302.40 ± 
25.32 
576.37 ± 
200.97 
453.40 ± 
79.97 
1043.90 
± 22.34 
 
766.20 ± 
34.65 
Sr - 166.53 ± 
7.18 
- 64.63 ± 
15.73 
- 23.87± 
2.54 
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Figure 40. Si concentration as a function of medium immersion time 
 
As seen in Figure 40, highest Si release was detected for 1/99 hybrids. Also during 72h 
pre-incubation, 1/99 hybrids possess the highest Si concentrations. In general, the Si 
concentration can be seen to increase with decreasing glass content of the hybrid.   
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Figure 41. Ca concentration as a function of medium immersion time 
 
As seen in Figure 41, Ca concentration is seen to stay quite constant upon medium 
immersion without big differences between hybrids.  
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Figure 42. P concentration as a function of medium immersion time 
 
As seen in Figure 42, P concentration is decreasing upon immersion quite drastically, 
which would suggest high reactivity and rapid HA layer precipitation.  
Boron and Strontium concentration from borosilicate hybrids is seen below:  
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Figure 43. B concentration as a function of medium immersion time  
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When comparing different mix hybrid compositions, B concentration depends 
unsurprisingly on the BAG content: the higher the BAG content, the higher in the release 
of B.  
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Figure 44. Sr concentration as a function of medium immersion time 
 
Similar trend for Sr ions is seen as for B ions: higher Bag content indicates higher release 
of Sr ions.  
 
Rest of ICP-results for each element individually are found in the Appendix.  
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7.  DISCUSSION 
7.1 pH measurements 
Assessing how the different hybrid samples affect the pH-value of surrounding solution 
is important in order to determine whether material would be suitable for cell culturing. 
The transient local microenvironment due to scaffold resorption might cause big effects 
on cell proliferation and function. For example, Monfoulet et al. found that excessive 
alkalinisation (pH > 7.90) in the microenvironment of hBMSCs inhibits osteogenic 
differentiation (Monfoulet, Becquart et al. 2014) 
Overall, both hybrids were found to show pH increase. Borosilicate –containing hybrids 
were found slightly more basic. The most logical explanation to this behaviour is the 
alkalinisation effect by bioactive glasses. Bioactive glasses consume protons during the 
ion exchange reactions, and release alkaline ions when resorbing, which increases the 
pH. In addition, during the gelation and hybrid synthesis process multiple not well-known 
chemical reactions occur between glass, gelatin and GPTMS, which might contribute to 
this pH increase. As discussed earlier it has been shown that the pH also affects to the 
hybrid coupling reactions. For instance, too acidic pH value during hybrid synthesis 
would lead to degradation of polymer, and too basic pH value would inhibit the epoxy 
ring opening of GPTMS. (Gabrielli, Russo et al. 2013)  
However, measuring pH using pH paper would give only a rough idea of the pH value. 
In addition, pH meter available has quite wide error of measurements (± 0.02). When 
synthesizing hybrids, gelation point and complete transition from viscous liquid to viscous 
solid can be seen. This limits the possibilities to measure pH value of gelating hybrid 
solution. In addition, pH values were measured only from composition with 30/70 wt-% 
between glass and gelatin. Studying the pH-value changes for other compositions would 
have given valuable information about the level of pH during hybrid synthesis.  
7.2 Thermogravimetric (TGA) analysis 
 
TGA analysis can be used to evidence successful grafting of GPTMS to both gelatin and 
bioactive glass. Also, in order to calculate the actual organic-inorganic ratio in the hybrid 
materials the results of TGA analysis are useful. 
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As seen in the calculations of the actual ratios between the organic and inorganic 
phases, the 30/70 hybrids are quite accurately representing the theoretical ratios.  
However, when designing our hybrid compositions, it would have been useful to take the 
weight of the GPTMS into account as well. Now in the results the residual mass 
represents the inorganic part of GPTMS and the glass, while all the organic material is 
burned away. Because over half of the weight of our hybrids actually comes from the 
GPTMS, now the labeling 30/70, 15/85, and so on only based on the ratio gelatin and 
BAGs is slightly misleading.  
Several other groups have made similar measurements earlier to hybrid materials. 
(Greenhalgh, Ambler et al. 2017, Lao, Dieudonné et al. 2016, Ghorbani, Zamanian et al. 
2018, Mondal 2018) Mondal measured for similar weight ratio 30/70 between inorganic 
and organic coupled with GPTMS residual mass ~55%, which is quite similar to our 
results. Furthermore, the curve shapes displayed similar behavior than in our results. 
The highest drop is observed between 300-400 °C, and the overall shape of the curve is 
very steep.   
 
7.3 In vitro dissolution 
For this study, dissolution was analysed by the means of SBF bioactivity measurement 
and enzymatic degradation study by collagenase. In vitro characteristics of BAGs, such 
as their dissolution rate and conversion to HA layer, are dependent primarily on glass 
composition and the microstructure of scaffold. (Rahaman, Day et al. 2011) The 
bioactivity and dissolution of BAGs is commonly studied by SBF immersion. In the case 
of hybrid materials, also the organic part with the coupling agent, and the range of 
covalent bonding between them plays an important role to determine the dissolution 
behaviour of the whole hybrid material.  
Mass loss of the hybrid samples measured upon immersion provides a measure of their 
degradation rate. Usually biomaterial scaffold is designed to degrade at same rate than 
tissue formation occurs at the implantation site. Benefit of degradable scaffold is that no 
foreign material stays in the body, biomaterial slowly disappears, and ultimately newly 
formed tissue fills out the space. (Rahaman, Day et al. 2011) 
The mass loss was found to be significantly higher for hybrids containing the silicate 
glass compared to the one (with similar glass content) containing the borosilicate 
bioactive glass. This is due to the dissolution of the samples, but probably also due to 
the washing effect of unreacted compounds. Also the higher mass loss for hybrid with 
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higher BAG content indicates that there are probably more free particles not grafted with 
GPTMS dissolving into the solution. However, the mass loss might be partially 
compensated by the HA precipitation.  
Detected increase in pH is due to the release of alkali metal (Na), and alkaline earth 
metal (Mg, Ca, Sr) ions, and due to the consumption of protons from the solution. This 
type of behaviour is typical in in vitro dissolution of both silicate and borosilicate bioactive 
glasses. When they dissolve, ions from the glass network are released to the solution. 
Contrary to pH results done during hybrid synthesis, in SBF immersion silicate glass 
S53P4 containing hybrids expressed higher pH than borosilicate hybrids.  
Similar results have been observed from earlier SBF dissolution studies made with same 
composition borosilicate glass. As shown before for same borosilicate B12.5 –Mg 5 –Sr 
10, also when this glass is a part of hybrids, it leads to pH increase in SBF immersion. 
(Tainio 2016, Tainio, Salazar et al. 2020) In the case of mass loss results, in earlier 
studies alginate silica hybrids with highest GPTMS content have been found to display 
highest mass loss for hybrids. (Vueva, Connell et al. 2018) In our case mass loss was 
found to be quite drastic for all hybrid samples. However, the impact of the GPTMS 
amount to mass loss is difficult to see because the same C factor was used for all hybrid 
samples. 
Si ions released by glass dissolution are known to play an essential role in bone 
formation. The concentration of Si ions increases upon SBF immersion as a function of 
time due to breaking of silica layers in the glass network. However, since our hybrids 
also included Si-containing coupling agent GPTMS, at least part of Si ion release comes 
from the GPTMS as well. Especially in the case of hybrids with less BAG, and therefore 
having fewer binding sites for GPTMS, the Si release is highest. This indicates the 
release of unreacted GPTMS molecules contributing to increasing Si concentration upon 
SBF immersion.  
HCA layer involves formation of silica-rich layer that act as nucleation site for CaP layer. 
Furthermore, the decrease of P concentration suggests CaP layer formation. From our 
results decrease of the concentrations of Ca and P ions is seen to all hybrids, which 
might indicate CaP layer formation. However, in order to ensure that, for example SEM 
images of the hybrid surfaces would give valuable information.  
However, the accuracy of SBF as a representative of in vivo conditions has been 
questioned (Kokubo, Takadama 2006, Bohner, Lemaitre 2009). SBF itself contains both 
calcium and phosphate ions, so therefore, in SBF solution hydroxyapatite can form solely 
from the solution. (Varila, Fagerlund et al. 2012) Especially issues when measuring Ca 
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and P concentrations might occur since SBF is already supersaturated towards the 
precipitation of HA.  
In addition, by comparing the thermogravimetric (TGA) results from samples before and 
after SBF immersion it is possible to get an idea of the possible changes in hybrid 
composition and stability upon immersion. However, the interpretation of these results is 
challenging due to the ungrafted GPTMS releasing into the solution upon SBF 
immersion. Therefore, the residual consists not only of BAG left but also the attached 
GPTMS. In addition to remained GPTMS and BAG, possible HA precipitation is also 
contributing to the residual, making the interpretation even more challenging.  
If gelatin is not properly functionalized by GPTMS, and GPTMS not linked to BAG phase, 
rapid and uncontrolled dissolution can occur, indicating instability of the hybrid. Covalent 
coupling is necessary to control the rate of degradation and mechanical properties of 
hybrid materials. Some idea of the degradation behaviour mimicking in vivo conditions 
can be assessed by using collagenase enzymatic degradation assay. However, in vitro 
degradation assays will always fail to completely imitate the complexity of in vivo context, 
where various cells and enzymes are present. Based on our enzymatic degradation 
results, very rapid and degradation of samples was detected for both hybrids with not 
much difference between them. However, if compared to gelatin alone, hybrids act as 
more stable gels, because they don’t dissolve to 37 °C solution immediately.  
 
7.4 Rheological properties 
Rheological properties of hybrids were assessed in order to evaluate the gel point and 
other viscoelastic properties of the hybrids. The rheological measurements were 
challenging to perform due to very narrow time window prior full gelation of the hybrids. 
It was possible to detect very quick transformation from transparent liquid to white and 
much less transparent viscous solution, and ultimately to a solid gel. This issue has been 
discussed previously with similar silica/gelatin hybrids (Nelson 2016). Also, due to 
observed shrinking of hybrids during their gelation, it was impossible to keep the axial 
force of the geometry positive after gelation point. If the axial force is lost (negative 
values), it indicates lost contact between the geometry and sample, leading to unreliable 
results.  
Due to the time-responsivity of GPTMS crosslinking, it was impossible to assess the 
viscosity as a function of temperature without gelation at certain time point. In order to 
accurately determine whether temperature changes affected hybrid viscosity, all the 
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temperature ramp measurements were carried out without adding the coupling agent 
GPTMS. This way it was possible to exclude the time-dependent viscosity increase 
caused by GPTMS. However, therefore no information about the real hybrid gelation as 
a function of temperature was obtained. The results show only the effect of the different 
BAG on the viscosity of the gels in different temperatures.  
In literature coupling agents are usually added afterwards due to the very fast gelation 
time also observed in this study. (Gao, Rahaman et al. 2013) Gao et al. also reported 
the use of GPTMS as coupling agent to lead to rapid formation of stiff gel, which was not 
suitable for bioprinting.  
In order to use hybrids for example as a bioink, it would need to fulfil criteria such as 
sufficient rheological properties: it needs to be fluid enough to be able to pass through a 
nozzle but also retain three dimensional shape and not collapse as layers are added. 
This bioink developing and optimizing stage is very time consuming, since lots of 
rheological measurements and mathematical modelling is needed to calculate 
appropriate “window of printability”. (Paxton, Smolan et al. 2017) In our case, it was 
evident that due to the relatively narrow viscosity window for printing, this type of hybrid, 
at least in the test composition 30/70 with C-factor 1000, would not be very effective as 
a bioink.  
7.5 Hybrid cytotoxicity  
 
Glass composition influences its ability to support proliferation of cells in vitro. In the case 
of bone tissue engineering applications, hBMSCs are often chosen based on the 
rationale that they have been well established as an ideal source of cell-based therapy 
for bone tissue engineering applications. (Montoro, Wan et al. 2014) In order to 
determine whether the BAG/gelatin GPTMS-coupled hybrids would support hBMSC 
proliferation and attachment Live/Dead staining were performed to gain qualitative 
insight of the cell morphology, proliferation and attachment.  
As indicated by Live/Dead assay results, it is clearly seen that the hybrid materials are 
inhibiting the proliferation and attachment of hBMSCs both when culturing in contact with 
the samples, and with hybrid dissolution product extracts indirectly. The most essential 
question to assess is whether this inhibition depends on the inorganic part of the hybrid, 
referring to the BAG, or on the organic content, referring to the gelatin functionalized with 
GPTMS.  
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In the case the inhibition is due to the BAGs, possible reasons include their too high 
reactivity. This would be shown as drastic pH changes, and high ion release levels, 
indicating rapid HA precipitation and BAG dissolution. In general, BAGs tend to induce 
alkalinization of the external medium, due to leaching of ions to surrounding aqueous 
solutions. Contrary to glass discs or other larger size particles, here <38 µm BAG 
particles were used in the hybrid samples. Small size particles have a large reactive 
surface area, which correspond to the reactivity of the BAGs. However, as shown in the 
SBF test, the reactivity of the used BAGs is probably not the main reason for the inhibition 
of the cell proliferation.  
The effect of Boron on osteogenic differentiation of hBMSCs is studied previously, and it 
was found that concentration higher than 1000 ng/ml inhibits the cell proliferation after 4 
days (Ying, Cheng et al. 2011)  As shown in the ICP-OES results, the levels of B in cell 
culturing medium exceed that value, which might be one reason for inhibition of 
proliferation. Also, Ca ion levels have been shown to affect cell proliferation. (McCullen, 
Zhan et al. 2010) However, in our case the hBMSCs are simultaneously exposed to 
several different ions, and therefore it is not straightforward to specify the effect of 
individual ions alone. Furthermore, S53P4-based borosilicates have been previously 
cultured with human adipose stem cells (hASCs) expressing similar ion release profiles, 
which would suggest that the toxic level of ion release is not only option to proliferation-
inhibition effect of hybrids. (Ojansivu, Mishra et al. 2018) 
 In addition to toxic level of ions and pH increase, it is possible that unreacted excessive 
GPTMS contributes to low cell proliferation. It is probable that from the hybrids unreacted 
GPTMS is released into the medium, which is seen as high Si concentrations, when ICP-
OES measurements were conducted to culturing medium. Despite of the washing effect 
of unreacted compounds in 72h sample pre-incubation, there might be still unreacted 
GPTMS left. 
In literature polymer functionalization with GPTMS is found to be most effective in mildly 
acidic conditions, which favours GPTMS epoxy ring opening and reaction with polymer. 
(Connell, Gabrielli et al. 2017) In our case, adding of GPTMS and bioactive glass were 
carried out simultaneously, which might lead to insufficient reaction of GPTMS, leaving 
unreacted molecules to solution. As discussed earlier, the role of pH in GPTMS 
chemistry is crucial, which might also have an effect here. In addition, usually hybrids 
are synthesized with TEOS with much higher silica content, this would in theory yield 
more attachment sites for GPTMS than what BAG particles used here would. (Mahony, 
Tsigkou et al. 2010) 
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For these reasons, it would have been interesting to experiment with other possible 
coupling agents, such as (3-Aminopropyl)triethoxysilane (APTES). APTES is possible to 
graft with BAGs (Stanić 2017), and if it would be found to be able to graft also with gelatin, 
it would be one attractive option to try in the future experiments.  
Decrease in cell attachment might be also due to changes in the material matrix 
elasticity, surface chemistry or not suitable topography of the samples. This can be 
studied in direct contact but with indirect culturing in extracts this is not considered. 
Mahony et al. showed that BMSC cell attachment and morphology varied between 
hybrids, seeming that the C-factor affects. Higher C-factor was found to lead to an 
enhanced cell attachment and morphology, possibly due to improved rigidity and stability 
of hybrid (Mahony, Tsigkou et al. 2010) Due to this findings it would be interesting to 
experiment with ways to produce more rigid hybrid gels.  
In general, reactive materials such as BAGs are difficult to evaluate in in vitro conditions. 
This is due to the changes in environment: ion concentrations in the culturing medium, 
and pH changes as materials degrade. Engineering is needed to optimize the 
composition that releases suitable amount of therapeutic ions, and with not too dramatic 
pH changes. In vitro cell cultures are static, and therefore smaller ion amount can show 
material to be toxic to cells, but in reality, in in vivo conditions there is more dynamic flow, 
replenishment of body fluids would distribute ions. This can lead to false interpretations. 
For example, in an earlier work by Fu et al. 13-93-3b borate bioactive glass was found 
toxic to cells in vitro, but not in in vivo rat model. (Fu, Rahaman et al. 2010) Perhaps it 
would be beneficial to experiment with more in vivo -like conditions, such as culturing 
with more dynamic microenvironment. For example, gentle intermittent rocking of well 
plates might prevent local high concentrations of ions. 
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8. CONCLUSIONS 
Hybrid biomaterials, combining bioactive glasses (BAG) and natural polymers, such as 
gelatin, are potential alternatives for bone tissue engineering applications. In this thesis 
work GPTMS –coupled bioactive glass/gelatin hybrid biomaterials were synthesized and 
characterized in vitro with various methods. Firstly, the hybrid stability in aqueous 
solutions, such as Simulated Body Fluid (SBF) were demonstrated with multiple 
BAG/gelatin ratios. In addition, the hybrids showed controlled ion release upon SBF and 
cell medium immersion, suggesting HA layer precipitation indicating bioactivity. From 
enzymatic degradation studies hybrids were also found to be more resistant to enzymatic 
degradation than gelatin alone. Some preliminary rheological studies also gave some 
idea of the viscoelastic properties of the hybrids. Hybrids were found to gelate rapidly as 
a function of time with increasing G’ and G’’ moduli. BAG/gelatin gels without GPTMS 
were also found to exhibit higher viscosity as a function of decreasing temperature.  
However, some concerns are raised by the inhibitory effect of hybrid samples on human 
bone marrow –derived mesenchymal stem cell (hBMSC) proliferation. Cells are able to 
proliferate and attach to some extent for 24 hours, but after 72 hours strong inhibition on 
proliferation is detected for all compositions. This is probably due to the release of 
ungrafted GPTMS from the hybrids. Further optimization of the hybrid composition and 
more cell studies are needed to confirm the suitability of these hybrid biomaterials as a 
biocompatible bone tissue engineering scaffold material. For example, experimenting 
with more dynamic culturing methods, different C-factors or even different coupling 
agents such as APTES would be viable options for future trials. Ultimately, more optimal 
and biocompatible inorganic/organic hybrids would find multiple applications in bone 
tissue engineering due to their tailorable properties and shaping possibilities.  
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APPENDIX A: PROTOCOL FOR PREPARING 
SIMULATED BODY FLUID (SBF)  
 
1 litre of SBF is prepared by following adjusted Kokubo protocol below. (Kokubo, 
Kushitani et al. 1990) Reagents are diluted one by one in given order to distilled H2O:  
 
 Reagent Amount 
1 NaCl 7.996 g 
2 NaHCO3 0.35 g 
3 KCl 0.224 g 
4 K2HPO4 ∙ 3 H20 0.228 g 
5 MgCl2 ∙ 6 H2O 0.305 g 
6 1 M HCl ~40 ml 
7 CaCl2 ∙ 2 H2O 0.368 g 
8 Na2SO4 0.071 g 
9 Trizma-base 
2-Amino-2-(hydroxymethyl)-1,3-propane-diol 
6.057 g 
 
pH value is adjusted at 37.00 ± 0.02 to 7.40 ± 0.02 with 1 M HCl. SBF is stored in 
polyethylene bottle in fridge at 5-10 °C for maximum 30 days.  
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APPENDIX B: ICP-OES RESULTS 
 
Individual ion concentrations from SBF dissolution series 
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Combined ion concentration for S53P4 and mix hybrids from enzymatic 
degradation test 
 
0 1 2 3 4 5 6 7 8
0
200
400
600
800
1000
1200
1400
1600
1800
2000
 
 
C
o
n
c
e
n
tr
a
ti
o
n
 (
µ
g
/ m
l)
Time (h)
 Ca
 Mg
 Na
 P
 Si
 
Figure 45. 30/70 S53P4 hybrid ion concentrations 
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Figure 46. 30/70 mix hybrid ion concentrations  
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Individual ion concentrations from cell culturing medium 
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